var title_f7_27_7600="Placement of word catheter";
var content_f7_27_7600=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Placement of Word catheter in a Bartholin gland cyst cavity after drainage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7600=[""].join("\n");
var outline_f7_27_7600=null;
var title_f7_27_7601="Deptropine: International drug information";
var content_f7_27_7601=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"9\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Deptropine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F7292213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Brontin (IT);",
"     </li>",
"     <li>",
"      Brontina (GB);",
"     </li>",
"     <li>",
"      Deptropine Drank FNA (NL);",
"     </li>",
"     <li>",
"      Su-Brontine (GB)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1978452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Deptropine Citrate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihistamine",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of respiratory-tract disorders",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Adults: 0.5-1 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, as citrate: 1 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10363 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-113.53.254.124-C33D2BEBF2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7601=[""].join("\n");
var outline_f7_27_7601=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7292213\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978452\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978454\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978457\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978453\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821233\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978456\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10363\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10363|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_27_7602="F solani microscopy";
var content_f7_27_7602=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fusarium solani microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 340px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fusarium solani observed on microscopy. The patient had Fusarium keratitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of www.doctorfungus.org &copy;2006. Reproduced with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7602=[""].join("\n");
var outline_f7_27_7602=null;
var title_f7_27_7603="Venoarterial ECMO";
var content_f7_27_7603=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F80969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F80969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Veno-arterial (VA) ECMO for cardiac and/or respiratory failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 454px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Demonstrated here with right internal jugular vein drainage and right carotid artery infusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Van Meurs, K, Lally, KP, Peek, G, Zwischenberger, JB. ECMO: Extracorporeal Cardiopulmonary Support in critical care, Extracorporeal Life Support Organization, Ann Arbor 2005.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7603=[""].join("\n");
var outline_f7_27_7603=null;
var title_f7_27_7604="Parasternal long axis color Doppler echo AR";
var content_f7_27_7604=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/76115/laxcdars_conv.mp4?title=Parasternal+long+axis+color+Doppler+echo+AR\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parasternal long axis echocardiogram with color Doppler showing aortic regurgitation and a dilated aortic root",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 249px; height: 446px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The parasternal long axis view with color Doppler demonstrates severe aortic regurgitation associated with marked dilatation of the aortic root.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7604=[""].join("\n");
var outline_f7_27_7604=null;
var title_f7_27_7605="Glucarpidase: Drug information";
var content_f7_27_7605=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Glucarpidase: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?8/43/8883?source=see_link\">",
"    see \"Glucarpidase: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/35/35380?source=see_link\">",
"    see \"Glucarpidase: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F14266243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Voraxaze&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F8092321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidote;",
"     </li>",
"     <li>",
"      Enzyme",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F8092342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Methotrexate toxicity:",
"     </b>",
"     I.V.: 50 units/kg (Buchen, 2005; Widemann, 1997; Widemann, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Intrathecal methotrexate overdose (unlabeled route/use):",
"     </b>",
"     Intrathecal: 2000 units as soon as possible after accidental overdose (Widemann, 2004)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F8092341\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/35/35380?source=see_link\">",
"      see \"Glucarpidase: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Methotrexate toxicity:",
"     </b>",
"     I.V.: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Intrathecal methotrexate overdose (unlabeled route/use):",
"     </b>",
"     Intrathecal: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F8092343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13743141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13743140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in the manufacturer&rsquo;s labeling; has not been studied.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13743258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Voraxaze&reg;: 1000 units [contains lactose 10 mg/vial]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F13743098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11233912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Voraxaze&reg; is distributed through ASD Healthcare; procurement information is available (24 hours a day; 365 days a year) at 1-855-7-VORAXAZE (1-855-786-7292). Voraxaze&reg; is also commercially available in the U.S. through certain pharmacy wholesalers on a drop-ship basis; orders will only be processed during business hours for overnight delivery. For additional information, refer to  file://www.btgplc.com/products/specialty-pharmaceuticals/voraxaze.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F8092344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Infuse over 5 minutes; flush I.V. line before and after glucarpidase administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intrathecal (for intrathecal methotrexate overdose; unlabeled route/use): Glucarpidase was administered within 3-9 hours of accidental intrathecal methotrexate overdose in conjunction with lumbar drainage or ventriculolumbar perfusion (Widemann, 2004). Administered over 5 minutes via lumbar route, ventriculostomy, Ommaya reservoir, or lumbar and ventriculostomy (O'Marcaigh, 1996; Widemann, 2004). In one case report, 1000 units was administered through the ventricular catheter over 5 minutes and another 1000 units was administered through the lumbar catheter (O'Marcaigh, 1996).",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F13743116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F13717099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of toxic plasma methotrexate concentrations (&gt;1 micromole/L) in patients with delayed clearance due to renal impairment",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Due to the risk of subtherapeutic methotrexate exposure, glucarpidase is",
"     <b>",
"      NOT",
"     </b>",
"     indicated when methotrexate clearance is within expected range (plasma methotrexate concentration &le;2 standard deviations of mean methotrexate excretion curve specific for dose administered)",
"     <b>",
"      or",
"     </b>",
"     with normal renal function or mild renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F8092322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rescue agent to reduce methotrexate toxicity in patients with accidental intrathecal methotrexate overdose",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F8092328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Miscellaneous: Antiglucarpidase antibody development (17%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Flushing (2%), hypotension (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea/vomiting (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Paresthesia (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Allergic reaction, blurred vision, diarrhea, head pressure, hypersensitivity, hypertension, rash, shaking, throat irritation/tightness, tremor, warmth",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F13743103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F8092323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Allergic reaction: Serious allergic reactions have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Leucovorin calcium: Leucovorin calcium administration should be continued after glucarpidase; the same dose as was given prior to glucarpidase should be continued for the first 48 hours after glucarpidase; after 48 hours, leucovorin doses should be based on methotrexate concentrations. A single methotrexate concentration should not determine when leucovorin should be discontinued; continue leucovorin until the methotrexate concentration remains below the threshold for leucovorin treatment for &ge;3 days. Leucovorin calcium is a substrate for glucarpidase and may compete with methotrexate for binding sites;",
"     <b>",
"      do not administer leucovorin calcium within 2 hours before or after glucarpidase.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: In addition to leucovorin, glucarpidase use should be accompanied with adequate hydration and urinary alkalinization.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Intrathecal methotrexate overdose: Glucarpidase for intrathecal methotrexate overdose (unlabeled route/use) should be used in conjunction with immediate lumbar drainage; concurrent dexamethasone (4 mg I.V. every 6 hours for 4 doses) may minimize methotrexate-induced chemical arachnoiditis; leucovorin calcium (100 mg I.V. every 6 hours for 4 doses) may prevent systemic methotrexate toxicity (Widemann, 2004).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Monitoring methotrexate: During the first 48 hours after glucarpidase administration, the only reliable method of measuring methotrexate concentrations is the chromatographic method. DAMPA, an inactive methotrexate metabolite with a half-life of 9 hours, may interfere with immunoassay and result in the overestimation of the methotrexate concentration (when collected within 48 hours of glucarpidase administration).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F14395087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F14395085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leucovorin Calcium-Levoleucovorin: Glucarpidase may decrease serum concentrations of the active metabolite(s) of Leucovorin Calcium-Levoleucovorin. Specifically, 6S-5-methyltetrahydrofolateconcentrations may be reduced. Glucarpidase may decrease the serum concentration of Leucovorin Calcium-Levoleucovorin.  Management: Avoid leucovorin administration within 2 hours of glucarpidase dosing.  Continue to administer the pre-glucarpidase leucovorin dose for at least the first 48 hours after glucarpidase administration, and dose based on methotrexate concentration thereafter.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F13743100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13743101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. If administered to a pregnant woman, the risk to the fetus is unknown; use only if clearly needed. In general, medications used as antidotes should take into consideration the health and prognosis of the mother.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13743113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13743102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Caution should be used if administered to a breast-feeding woman.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Voraxaze Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 unit (1): $27000.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F8092347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serum methotrexate levels: Use chromatographic method if &lt;48 hours from glucarpidase administration  (DAMPA interferes with immunoassay results until &gt;48 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CBC with differential, bilirubin, ALT, AST, serum creatinine; evaluate for signs/symptoms of methotrexate toxicity",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F8092335\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Recombinant enzyme which rapidly hydrolyzes the carboxyl-terminal glutamate residue from extracellular methotrexate into inactive metabolites (DAMPA and glutamate), resulting in a rapid reduction of methotrexate concentrations independent of renal function",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F8092337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Methotrexate toxicity: Reduces methotrexate concentrations by &ge;97% within 15 minutes of I.V. administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: Methotrexate toxicity: Maintains a &gt;95% reduction of methotrexate concentrations for up to 8 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : I.V.: 3.6 L; distribution restricted to plasma volume",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: I.V.: Normal renal function: 6-9 hours; impaired renal function (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute): 8-10 hours (Phillips, 2008)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Buchen S, Ngampolo D, Melton RG, et al, &ldquo;Carboxypeptidase G2 Rescue in Patients With Methotrexate Intoxication and Renal Failure,&rdquo;",
"      <i>",
"       Br J Cancer",
"      </i>",
"      , 2005, 92(3):480-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/15668713/pubmed\" id=\"15668713\" target=\"_blank\">",
"        15668713",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Christensen AM, Pauley JL, Molinelli AR, et al, &ldquo;Resumption of High-Dose Methotrexate After Acute Kidney Injury and Glucarpidase Use in Pediatric Oncology Patients,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 2012, 118(17):4321-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/22252903/pubmed\" id=\"22252903\" target=\"_blank\">",
"        22252903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Krause AS, Weihrauch MR, Bode U, et al, &ldquo;Carboxypeptidase-G2 Rescue in Cancer Patients With Delayed Methotrexate Elimination After High-Dose Methotrexate Therapy,&rdquo;",
"      <i>",
"       Leuk Lymphoma",
"      </i>",
"      , 2002, 43(11):2139-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/12533039/pubmed\" id=\"12533039\" target=\"_blank\">",
"        12533039",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      O'Marcaigh AS, Johnson CM, Smithson WA, et al, \"Successful Treatment of Intrathecal Methotrexate Overdose by Using Ventriculolumbar Perfusion and Intrathecal Instillation of Carboxypeptidase G2,\"",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1996, 71(2):161-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/8577190/pubmed\" id=\"8577190\" target=\"_blank\">",
"        8577190",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Phillips M, Smith W, Balan G, et al, &ldquo;Pharmacokinetics of Glucarpidase in Subjects With Normal and Impaired Renal Function,&rdquo;",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 2008, 48(3):279-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/18192538/pubmed\" id=\"18192538\" target=\"_blank\">",
"        18192538",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schwartz S, Borner K, Muller K, et al, &ldquo;Glucarpidase (Carboxypeptidase G2) Intervention in Adult and Elderly Cancer Patients With Renal Dysfunction and Delayed Methotrexate Elimination After High-Dose Methotrexate Therapy,&rdquo;",
"      <i>",
"       Oncologist",
"      </i>",
"      , 2007 12(11):1299-308.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/18055849/pubmed\" id=\"18055849\" target=\"_blank\">",
"        18055849",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith SW and Nelson LS, &ldquo;Case Files of the New York City Poison Control Center: Antidotal Strategies for the Management of Methotrexate Toxicity,&rdquo;",
"      <i>",
"       J Med Toxicol",
"      </i>",
"      , 2008, 4(2):132-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/18570175/pubmed\" id=\"18570175\" target=\"_blank\">",
"        18570175",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Widemann BC, Balis FM, Kim A, et al, &ldquo;Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2010, 28(25):3979-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/20679598/pubmed\" id=\"20679598\" target=\"_blank\">",
"        20679598",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Widemann BC, Balis FM, Murphy RF, et al, &ldquo;Carboxypeptidase-G2, Thymidine, and Leucovorin Rescue in Cancer Patients With Methotrexate-Induced Renal Dysfunction,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1997, 15(5):2125-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/9164227/pubmed\" id=\"9164227\" target=\"_blank\">",
"        9164227",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Widemann BC, Balis FM, Shalabi A, et al, &ldquo;Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G2,&rdquo;",
"      <i>",
"       J Natl Cancer Inst",
"      </i>",
"      , 2004, 96(20):1557-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/27/7605/abstract-text/15494606/pubmed\" id=\"15494606\" target=\"_blank\">",
"        15494606",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9048 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-27.109.116.13-B2EFA6BE5C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7605=[""].join("\n");
var outline_f7_27_7605=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14266243\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092321\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092342\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092341\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092343\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743141\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743140\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743258\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743098\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11233912\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092344\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743116\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13717099\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092322\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092328\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743103\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092323\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14395087\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14395085\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743100\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743101\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743113\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13743102\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322584\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092347\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092335\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8092337\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9048\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9048|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?8/43/8883?source=related_link\">",
"      Glucarpidase: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/35/35380?source=related_link\">",
"      Glucarpidase: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_27_7606="Long-term management and prevention of urinary tract infections in children";
var content_f7_27_7606=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Long-term management and prevention of urinary tract infections in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Nader Shaikh, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Alejandro Hoberman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7606/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/27/7606/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract infection (UTI) is a frequently occurring clinical problem in childhood. Upper urinary tract infections (ie, acute pyelonephritis) may lead to renal scarring, hypertension, and end-stage renal dysfunction. Although children with pyelonephritis tend to present with fever, it is often difficult on clinical grounds to distinguish cystitis from pyelonephritis, particularly in young children (aged &lt;2 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/1\">",
"     1",
"    </a>",
"    ]. Thus, we have defined UTI broadly here without attempting to distinguish cystitis from pyelonephritis. Acute cystitis in older children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/59/42937?source=see_link\">",
"     \"Acute cystitis in children older than two years and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The long-term management and prevention of UTI in children will be reviewed here. The epidemiology, risk factors, clinical features, diagnosis, acute management, and prognosis of UTI in children and UTI in newborns are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26360?source=see_link\">",
"     \"Epidemiology and risk factors for urinary tract infections in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/1/27674?source=see_link\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/59/14264?source=see_link\">",
"     \"Urinary tract infections in newborns\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LONG-TERM MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Recurrent symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 8 to 30 percent of children with urinary tract infection (UTI) experience one or more symptomatic reinfections [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Breakthrough UTI are most common in girls [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Progression of renal scarring is associated with recurrent episodes of pyelonephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. Accordingly, prompt diagnosis and treatment of these infections is critically important in reducing renal scarring [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/2,11,12\">",
"     2,11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Families of young children with UTI should receive instruction about the risk of recurrent UTI and be advised to seek medical attention promptly for fever",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urinary symptoms. The evaluation of these episodes should include urinalysis, urine culture, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/1,13\">",
"     1,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Laboratory evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Children with VUR",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term management and follow-up of children with vesicoureteral reflux (VUR) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link\">",
"     \"Management of vesicoureteral reflux\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Children with bowel and bladder dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important task in the management of children with UTI, especially those with recurrent UTI, is to identify children with underlying bowel and bladder dysfunction. Approximately one out of five children with UTI is likely to have untreated bowel and bladder dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link\">",
"     \"Etiology and clinical features of bladder dysfunction in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of bowel and bladder dysfunction reduces the likelihood of UTI recurrences and is associated with faster resolution of VUR [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Treatment of bowel and bladder dysfunction should be initiated by the primary care provider. The first steps in the treatment of bowel and bladder dysfunction include timed voiding (scheduled voids every two to three hours), \"double\" voiding (asking children to sit and urinate again right after they voided), avoidance of C's (carbonated drinks, caffeine, citrus, chocolate, and food colorants),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the use of laxatives for children with constipation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/19\">",
"     19",
"    </a>",
"    ]. In chronically constipated children, treatment with laxatives has been shown to significantly reduce recurrences of UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=see_link&amp;anchor=H4#H4\">",
"     \"Management of bladder dysfunction in children\", section on 'Conservative management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Referral to a",
"    <span class=\"nowrap\">",
"     nephrologist/urologist",
"    </span>",
"    for further management (pelvic floor muscle training with biofeedback, anticholinergics) is recommended if the patient's symptoms do not respond to the initial management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PREVENTION OF RECURRENT UTI IN CHILDREN WITHOUT VUR",
"    </span>",
"    &nbsp;&mdash;&nbsp;To prevent renal scarring, risk factors for subsequent infection must be addressed. The discussion below focuses on prevention of recurrent urinary tract infection (UTI) in children who do not have vesicoureteral reflux (VUR), urinary obstruction, or bowel and bladder dysfunction. The management of VUR and bowel and bladder dysfunction are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link\">",
"     \"Management of vesicoureteral reflux\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=see_link\">",
"     \"Management of bladder dysfunction in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Surveillance cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine surveillance cultures for asymptomatic children after their first UTI should not be performed. In a study comparing oral and intravenous antibiotics for UTI in children, routine surveillance of asymptomatic children did not enhance identification of true UTI episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/2\">",
"     2",
"    </a>",
"    ]. Further, treatment of patients who have bacteriuria without symptoms is unproven and may be harmful [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Asymptomatic bacteriuria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several randomized trials have evaluated the benefit of prophylactic antibiotics in preventing recurrent UTI in children, but most studies included only children with VUR [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/22\">",
"     22",
"    </a>",
"    ]. Three trials included children with and without VUR, but none was powered to detect differences in efficacy in the subgroup of children without VUR [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. A meta-analysis of individual data restricted to young children 2 to 24 months of age without VUR did not detect a benefit for prophylaxis in preventing recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/13\">",
"     13",
"    </a>",
"    ]. Importantly, very few children in the three trials had history of recurrent UTIs; two trials restricted enrollment to children with a first UTI and one trial included &lt;30 percent of children with recurrent UTI. Thus, although available data suggest that routine prophylactic antibiotics are not beneficial after a first UTI in children without VUR, there are few data to guide care of children with frequent recurrent UTIs.",
"   </p>",
"   <p>",
"    We suggest antimicrobial prophylaxis in children without vesicoureteral reflux (VUR) who have frequent recurrent UTIs (three febrile UTIs in six months or four total UTIs in one year). When prescribing antimicrobial prophylaxis, we generally suggest",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (TMP-SMX) 2 mg",
"    <span class=\"nowrap\">",
"     TMP/kg",
"    </span>",
"    as a single daily dose or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/21/10581?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    as a single daily dose for six months. Antimicrobial prophylaxis can be discontinued if no infection occurs during the period of prophylaxis; if infection recurs, resumption of prophylaxis may be warranted. The management of children with VUR is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link\">",
"     \"Management of vesicoureteral reflux\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cranberry juice",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not routinely suggest cranberry juice for the prevention of recurrent UTI in children. In a meta-analysis of 13 studies including children and adults (n = 2462), cranberry products did not reduce the occurrence of symptomatic UTI compared with placebo, water, or no treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/26\">",
"     26",
"    </a>",
"    ]. Meta-analysis of two studies limited to children with recurrent UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7606/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] also found no benefit. Although cranberry juice in moderation is unlikely to be harmful, excessive intake may contribute to dental caries, diarrhea, and obesity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/38/10850?source=see_link\">",
"       \"Patient information: Urinary tract infections in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/58/38818?source=see_link\">",
"       \"Patient information: Urinary tract infections in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Families of young children with urinary tract infection (UTI) should receive instruction about the risk of recurrent UTI and be advised to seek medical attention promptly for fever",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      urinary symptoms. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Recurrent symptoms'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26360?source=see_link&amp;anchor=H20#H20\">",
"       \"Epidemiology and risk factors for urinary tract infections in children\", section on 'Risk factors for renal scarring'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The evaluation for episodes of fever",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      urinary symptoms should include a properly collected urine specimen (using bladder catheterization in children who are not toilet trained) which is then sent for urinalysis, urine culture, or both. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Laboratory evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The treatment of bowel and bladder dysfunction may include timed voiding, \"double voiding,\" the use of laxatives,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      referral to a urologist. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Children with bowel and bladder dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine surveillance cultures in asymptomatic children after their first UTI are unnecessary. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Surveillance cultures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest antimicrobial prophylaxis in children without vesicoureteral reflux (VUR) who have frequent recurrent UTIs (three febrile UTIs in six months or four total UTIs in one year) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"       Trimethoprim-sulfamethoxazole",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/21/10581?source=see_link\">",
"       nitrofurantoin",
"      </a>",
"      may be used for prophylaxis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prophylactic antibiotics are usually continued for six months. They can be discontinued if no infection occurs during the period of prophylaxis. Resumption of prophylaxis may be warranted if infection recurs. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not routinely suggest cranberry juice for the prevention of recurrent UTI in children (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cranberry juice'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The long-term management and follow-up of children with vesicoureteral reflux are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link\">",
"       \"Management of vesicoureteral reflux\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/1\">",
"      Hoberman A, Charron M, Hickey RW, et al. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003; 348:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/2\">",
"      Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999; 104:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/3\">",
"      Conway PH, Cnaan A, Zaoutis T, et al. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007; 298:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/4\">",
"      Peters CA, Skoog SJ, Arant BS Jr, et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol 2010; 184:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/5\">",
"      Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010; 126:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/6\">",
"      Goldraich NP, Goldraich IH. Followup of conservatively treated children with high and low grade vesicoureteral reflux: a prospective study. J Urol 1992; 148:1688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/7\">",
"      Panaretto K, Craig J, Knight J, et al. Risk factors for recurrent urinary tract infection in preschool children. J Paediatr Child Health 1999; 35:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/8\">",
"      Martinell J, Hansson S, Claesson I, et al. Detection of urographic scars in girls with pyelonephritis followed for 13-38 years. Pediatr Nephrol 2000; 14:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/9\">",
"      Wennerstr&ouml;m M, Hansson S, Jodal U, Stokland E. Primary and acquired renal scarring in boys and girls with urinary tract infection. J Pediatr 2000; 136:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/10\">",
"      Merrick MV, Notghi A, Chalmers N, et al. Long-term follow up to determine the prognostic value of imaging after urinary tract infections. Part 2: Scarring. Arch Dis Child 1995; 72:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/11\">",
"      Hiraoka M, Hashimoto G, Tsuchida S, et al. Early treatment of urinary infection prevents renal damage on cortical scintigraphy. Pediatr Nephrol 2003; 18:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/12\">",
"      Smellie JM, Poulton A, Prescod NP. Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ 1994; 308:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/13\">",
"      Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/14\">",
"      Shaikh N, Hoberman A, Wise B, et al. Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life? Pediatrics 2003; 112:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/15\">",
"      Mazzola BL, von Vigier RO, Marchand S, et al. Behavioral and functional abnormalities linked with recurrent urinary tract infections in girls. J Nephrol 2003; 16:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/16\">",
"      Koff SA, Lapides J, Piazza DH. Association of urinary tract infection and reflux with uninhibited bladder contractions and voluntary sphincteric obstruction. J Urol 1979; 122:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/17\">",
"      Koff SA, Murtagh DS. The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution. J Urol 1983; 130:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/18\">",
"      Seruca H. Vesicoureteral reflux and voiding dysfunction: a prospective study. J Urol 1989; 142:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/19\">",
"      Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr 2006; 18:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/20\">",
"      Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics 1997; 100:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/21\">",
"      Hansson S, Jodal U, Nor&eacute;n L, Bjure J. Untreated bacteriuria in asymptomatic girls with renal scarring. Pediatrics 1989; 84:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/22\">",
"      Williams G, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 2011; :CD001534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/23\">",
"      Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 2009; 361:1748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/24\">",
"      Garin EH, Olavarria F, Garcia Nieto V, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006; 117:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/25\">",
"      Montini G, Rigon L, Zucchetta P, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 2008; 122:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/26\">",
"      Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2012; 10:CD001321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/27\">",
"      Salo J, Uhari M, Helminen M, et al. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trial. Clin Infect Dis 2012; 54:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7606/abstract/28\">",
"      Ferrara P, Romaniello L, Vitelli O, et al. Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scand J Urol Nephrol 2009; 43:369.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6066 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-4F64B2DDF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7606=[""].join("\n");
var outline_f7_27_7606=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LONG-TERM MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Recurrent symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Children with VUR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Children with bowel and bladder dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PREVENTION OF RECURRENT UTI IN CHILDREN WITHOUT VUR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Surveillance cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cranberry juice",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/59/42937?source=related_link\">",
"      Acute cystitis in children older than two years and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/1/27674?source=related_link\">",
"      Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=related_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26360?source=related_link\">",
"      Epidemiology and risk factors for urinary tract infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=related_link\">",
"      Etiology and clinical features of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=related_link\">",
"      Management of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=related_link\">",
"      Management of vesicoureteral reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/58/38818?source=related_link\">",
"      Patient information: Urinary tract infections in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/38/10850?source=related_link\">",
"      Patient information: Urinary tract infections in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/59/14264?source=related_link\">",
"      Urinary tract infections in newborns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_27_7607="Acupuncture for rheumatic conditions";
var content_f7_27_7607=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acupuncture for rheumatic conditions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7607/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7607/contributors\">",
"     Edzard Ernst, MD, PhD, FMEdSci, FSB, FRCP, FRCP (Edin.)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7607/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7607/contributors\">",
"     Daniel E Furst, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7607/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7607/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/27/7607/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ancient Chinese texts describe an elaborate system of acupuncture. Acupuncture is still routinely used in China, Japan, Korea, and other Eastern countries [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/1\">",
"     1",
"    </a>",
"    ]. In the West, further interest in acupuncture began in the 1970s. As with many other forms of &ldquo;alternative&rdquo; medicine, acupuncture is used by patients suffering from rheumatic diseases to alleviate chronic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acupuncture can be defined as the insertion of one or more dry needles into the skin and underlying tissues at acupuncture points. These points may also be stimulated by pressure (acupressure), laser, ultrasound, heat (moxibustion), or electricity (electroacupuncture). The combination of electroacupuncture with needle placement down to the periosteum is referred to as periosteal stimulation or osteopuncture.",
"   </p>",
"   <p>",
"    A review of the efficacy of acupuncture for rheumatic conditions is presented here. A general discussion of acupuncture is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28457?source=see_link\">",
"     \"Acupuncture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     AN ACUPUNCTURE VISIT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most commonly, an acupuncture visit begins with a history and examination of the tongue, face, and pulse. Subsequently, several needles (typically fewer than a dozen) are inserted, and then they either are manipulated by hand or are used to transmit electrical stimuli. Treatment for a single complaint consists of 6 to 12 sessions scheduled over several months, each lasting approximately 30 minutes or less [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/3\">",
"     3",
"    </a>",
"    ]. Several maintenance sessions per year may be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     POSSIBLE MECHANISMS OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acupuncture is primarily used to relieve pain. There are traditional and scientific explanations for its possible mechanism of action.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Traditional explanation",
"    </span>",
"    &nbsp;&mdash;&nbsp;One fundamental concept in acupuncture is &ldquo;Qi,&rdquo; which is usually translated as &ldquo;energy.&rdquo; Traditional acupuncturists believe that Qi is inherited at birth and is maintained during life by the intake of food and air. It circulates throughout the body, nourishing every part. The major circulatory pathways are 12 meridians that form a continuous network. More than 350 acupuncture points are located on these meridians.",
"   </p>",
"   <p>",
"    Health is viewed as a balance of two opposites, yin and yang. Diseases are due to disturbances, disharmony, or imbalances of these opposites. The body can be stimulated to correct its own energy flow and balance by acupuncture [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Scientific explanation",
"    </span>",
"    &nbsp;&mdash;&nbsp;No compelling evidence exists to confirm the physical existence of Qi or of the meridians. For Western acupuncturists, these points are instead sites at which nerves can be stimulated; thus, acupuncture is considered a method of stimulating nerves and muscles. Evidence in support of this hypothesis includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acupuncture releases various neurotransmitters and neuromodulators, including opioid peptides, serotonin, and adenosine [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/4-6\">",
"       4-6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      , an opioid antagonist, prevents acupuncture-associated analgesia [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acupuncture stimulates large, myelinated, rapidly conducting A-delta nerve fibers that may serve to decrease transmission of painful sensations via slower, unmyelinated C fibers [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Numerous functional magnetic resonance imaging (MRI) studies have suggested supraspinal mechanisms of acupuncture. However, one review disclosed numerous problems with these investigations and concluded that these findings may be caused by methodological flaws [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5067563\">",
"    <span class=\"h1\">",
"     CLINICAL USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acupuncture may benefit patients with rheumatic conditions. However, no consensus exists as to what constitutes good acupuncture practice. It is, therefore, not possible to provide evidence-based guidelines on which acupuncture technique is best for which condition or for which patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EVIDENCE OF CLINICAL EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acupuncture is associated with a powerful placebo effect, and clinical trials of acupuncture face formidable methodological challenges [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although placebo-acupuncture (usually needling at non-acupuncture points) and patient blinding are usually achievable, therapist blinding is difficult.",
"     </li>",
"     <li>",
"      Many trials are of low methodological quality, and the results are frequently far from uniform [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is, therefore, problematic to rely upon single trials when evaluating the effectiveness of acupuncture for a given condition. The following discussion, therefore, relies mainly upon systematic reviews (primarily) of randomized controlled trials (RCTs) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Chronic pain of any etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;One systematic review evaluated 51 RCTs relating to acupuncture for the treatment of chronic pain of any etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/13\">",
"     13",
"    </a>",
"    ]. Limited evidence was found that acupuncture is more effective than no treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Osteoarthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acupuncture is frequently advocated as a treatment for osteoarthritis (OA). At least three systematic reviews concluded that acupuncture is more efficacious than the sham-control interventions used in the clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. However, differences between acupuncture and sham-controls, despite their statistical significance, may not represent differences that are clinically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/15\">",
"     15",
"    </a>",
"    ]. Data are inconclusive regarding whether traditional Chinese acupuncture is more effective than other types (eg, &ldquo;Western formula&rdquo;) of acupuncture.",
"   </p>",
"   <p>",
"    The patient-provider interaction itself may explain some of the benefit of both actual and sham acupuncture. In a trial involving 527 patients, performance of acupuncture with a style expressing high expectations resulted in statistically significant improvement in pain and satisfaction, compared with a style conveying neutral expectations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/17\">",
"     17",
"    </a>",
"    ]. These findings support the view that the benefits of acupuncture in this study were likely to be fully explained by the placebo effect [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electroacupuncture may have beneficial effects that are similar to, but perhaps longer lasting than, hydrotherapy. This was suggested by a study that randomly assigned subjects with OA of the hip to receive one of these interventions or patient education [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/19\">",
"     19",
"    </a>",
"    ]. There were significantly greater improvements in the mean levels of pain, function, and overall quality of life in those receiving either electroacupuncture or hydrotherapy than in the control group. Beneficial effects on pain and function lasted at least three months longer in the electroacupuncture group than in the hydrotherapy group. However, a meta-analysis of eight randomized trials concluded that substantial heterogeneity among the trials prevented a meaningful conclusion regarding the efficacy of electroacupuncture for peripheral OA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electrical stimulation via needles placed to the bone surface may result in greater pain relief than similar needle placement without electrical stimulation. This was illustrated in a study that randomly assigned 88 older adults with osteoarthritis of the knee either to a &ldquo;periosteal stimulation procedure&rdquo; (osteopuncture) or to a control procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/20\">",
"     20",
"    </a>",
"    ]. Periosteal stimulation consisted of 30 minutes of a 100 Hz electrical current applied to each of four needles after they were inserted until they touched bone (at the medial and lateral femoral condyles, fibular head, and medial tibial flare). The control group had similar needle placement, but the needles touching the periosteum were not electrically stimulated. In addition, both groups had two 30-gauge acupuncture needles placed in the soft tissues on the medial and lateral aspect of the lower leg below the knee, and these needles were stimulated for one minute with electrical current at 100 Hz and a minimally perceptible amperage. The periosteal stimulation group experienced a significantly greater reduction in pain in the immediate post-treatment period than did the control group (Western Ontario and McMaster Osteoarthritis Index [WOMAC] pain score decreased from baseline by 3.08 versus 1.02, respectively). The difference between the groups diminished with time and was no longer apparent three months after the electroacupuncture session.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Rheumatoid arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conflicting evidence exists concerning the efficacy of acupuncture in rheumatoid arthritis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One RCT evaluated 10 patients with rheumatoid arthritis (RA) and symmetric joint involvement; each subject had one knee treated with sham acupuncture and the other with real acupuncture [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/21\">",
"       21",
"      </a>",
"      ]. Patients noted significant improvement in pain relief in knees treated with real acupuncture compared with knees treated with sham acupuncture. The average pain-free duration was one to three months in the acupuncture-treated knee versus less than 10 hours in the sham acupuncture-treated knee.",
"     </li>",
"     <li>",
"      A second randomized crossover study of 56 patients with RA compared the efficacy of acupuncture with that of placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/22\">",
"       22",
"      </a>",
"      ]. There were no significant differences in pain relief, in the levels of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentration, or in the number of swollen or tender joints.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the results of these two studies are conflicting, the second is larger and more methodologically sound. Thus, there does not appear to be any significant beneficial effects of acupuncture on pain or inflammation in patients with RA. A 2008 systematic review concluded that the evidence is limited by methodological considerations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Fibromyalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Five randomized and controlled trials of acupuncture, all of which employed acupuncture as an adjunct to conventional therapies, were the subject of a systematic review [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/24\">",
"     24",
"    </a>",
"    ]. The quality of the studies, as assessed by the Jadad scale, was not high. The results of three studies suggested positive but short-lasting effects of acupuncture while there was no significant difference between acupuncture and control in the other two trials. The three positive studies were on electroacupuncture. The conclusion was that the effectiveness of acupuncture for patients with fibromyalgia has not been demonstrated in rigorous trials with adequate randomization and with appropriate control interventions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14586?source=see_link\">",
"     \"Initial treatment of fibromyalgia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5786?source=see_link&amp;anchor=H22300605#H22300605\">",
"     \"Treatment of fibromyalgia in adults not responsive to initial therapies\", section on 'Acupuncture'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5786?source=see_link\">",
"     \"Treatment of fibromyalgia in adults not responsive to initial therapies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Low back pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The data on efficacy of traditional Chinese acupuncture versus sham acupuncture and versus non-acupuncture interventions are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28457?source=see_link&amp;anchor=H21#H21\">",
"     \"Acupuncture\", section on 'Low back pain'",
"    </a>",
"    .) Most systematic reviews arrive at cautiously positive conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Neck pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The objective of another systematic review was to establish whether there is evidence for or against the effectiveness of acupuncture in the treatment of neck pain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/26\">",
"     26",
"    </a>",
"    ]. All RCTs that compared needle or laser acupuncture with a control procedure for the treatment of neck pain were included. Two reviewers independently extracted data concerning study methods, quality, and outcome. The results of 14 RCTs were balanced between positive and negative. Acupuncture was superior to waiting-list in one study and was either equal with or superior to physiotherapy in three studies. Needle acupuncture was not superior to indistinguishable sham control in four of five studies. Of the eight high-quality trials, five were negative. The hypothesis that acupuncture is effective in the treatment of neck pain was, therefore,",
"    <strong>",
"     not",
"    </strong>",
"    well-supported by available evidence at that time from sound clinical trials.",
"   </p>",
"   <p>",
"    Since the publication of the systematic review cited above, at least two well-designed trials did, however, note significant analgesic effects from acupuncture [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] which, in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/27\">",
"     27",
"    </a>",
"    ], lasted for at least three years. A 2006 systematic review of the treatment of chronic neck pain that compared acupuncture with various inactive sham treatments (ie, did not compare traditional Chinese acupuncture with needle insertions at nontraditional sites) concluded that acupuncture was more effective than sham controls in immediate post-treatment relief of neck pain (standardized mean difference -0.37, 95% CI -0.61 to -0.12) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Epicondylitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2004 systematic review of the effectiveness of acupuncture for lateral epicondylitis (tennis elbow) assessed data from six randomized or quasi-randomized controlled clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/30\">",
"     30",
"    </a>",
"    ]. There appeared to be &ldquo;strong evidence&rdquo; of short-term relief of elbow pain with acupuncture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=see_link\">",
"     \"Epicondylitis (tennis and golf elbow)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Myofascial trigger point pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct needle insertion at the site of myofascial pain may be of some benefit. This was illustrated in a 2001 systematic analysis of 23 randomized and controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/31\">",
"     31",
"    </a>",
"    ]. The authors concluded that direct needling of these sites appears to be effective, but it is unclear whether the response is due to a specific or nonspecific therapeutic effect. A 2008 systematic review and meta-analysis of four RCTs found acupuncture not to be significantly superior to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been argued that systematic reviews of acupuncture are based upon biased primary data and may, therefore, have generated false-positive results [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/33\">",
"     33",
"    </a>",
"    ]. Similarly it was shown that RCTs using the new nonpenetrating sham devices which adequately control for placebo effects have generated negative results, implying that most of the therapeutic response after acupuncture is due to placebo effects [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     EVIDENCE OF SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse effects have been associated with the use of acupuncture (",
"    <a class=\"graphic graphic_table graphicRef68241 \" href=\"UTD.htm?24/33/25116\">",
"     table 1",
"    </a>",
"    ). Systematic reviews of all case reports of life-threatening complications of acupuncture have found that such events fall into two main categories [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/25,34,35\">",
"     25,34,35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Infections (eg, hepatitis B)",
"     </li>",
"     <li>",
"      Trauma (eg, pneumothorax)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both are avoidable with adequate training and care, and they represent extremely rare events. As an example, in a prospective study that included 97,733 patients who received acupuncture treatments, there were only six potentially serious adverse events noted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/36\">",
"     36",
"    </a>",
"    ]. However, at least 86 deaths following acupuncture have been noted in the medical literature [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By comparison, mild and transient adverse events occur much more frequently [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/35,38\">",
"     35,38",
"    </a>",
"    ]. The reported incidence varies widely as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Based upon a review that included nearly a quarter of a million treatments, mild bleeding and aggravation of symptoms or of pain were noted in 0.03 to 38 percent and in 1 to 45 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/35\">",
"       35",
"      </a>",
"      ]. In the prospective study referred to above [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/36\">",
"       36",
"      </a>",
"      ], these adverse effects were noted in approximately 3 to 4 percent of those treated.",
"     </li>",
"     <li>",
"      A prospective British survey of 6348 patients noted no serious adverse effects and an overall incidence of non-serious adverse effects of 11 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/39\">",
"       39",
"      </a>",
"      ]. In 3 percent of these patients, acupuncturists were reported to interfere with the patients&rsquo; prescribed medications.",
"     </li>",
"     <li>",
"      A systematic review of adverse effects in children concluded that acupuncture is a safe treatment for pediatric patients [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a few absolute or relative contraindications to the use of acupuncture. These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe bleeding disorders are a contraindication for needle acupuncture.",
"     </li>",
"     <li>",
"      Pregnancy (first trimester) is regarded by some acupuncturists as a contraindication.",
"     </li>",
"     <li>",
"      The presence of a cardiac pacemaker is a contraindication for electrical stimulation.",
"     </li>",
"     <li>",
"      Indwelling needles should not be used in patients at risk from bacteremia, such as asplenic patients or those who may become neutropenic.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of syncope, drowsiness, pneumothorax, and sepsis lead to the following additional suggestions for patient safety [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7607/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients should be treated in a supine position, at least for their first session.",
"     </li>",
"     <li>",
"      Patients should not drive or operate machinery immediately after therapy.",
"     </li>",
"     <li>",
"      Children should be treated with special care.",
"     </li>",
"     <li>",
"      Needling sites on the thorax requires a sound knowledge of anatomy.",
"     </li>",
"     <li>",
"      Strict asepsis and close supervision are advised if indwelling needles are used.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5067580\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acupuncture can be defined as the insertion of one or more dry needles into the skin and underlying tissues at acupuncture points. These points may also be stimulated by pressure (acupressure), laser, ultrasound, heat (moxibustion), or electricity (electroacupuncture). Most commonly, several needles (typically fewer than a dozen) are inserted and then they either are manipulated by hand or are used to transmit electrical stimuli. Treatment for a single complaint typically consists of 6 to 12 sessions scheduled over several months, each lasting approximately 30 minutes or less, and may include several maintenance sessions per year. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'An acupuncture visit'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Traditional acupuncturists believe that Qi, a concept usually translated as &ldquo;energy,&rdquo; is inherited at birth, that it is maintained during life by the intake of food and air, and that it circulates throughout and nourishes the body. The major circulatory pathways are 12 meridians that form a continuous network. More than 350 acupuncture points are located on these meridians. Diseases are conceived of as being due to imbalances of yin and yang, two opposites, and acupuncture is a method to stimulate the body to correct its own energy flow and balance. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Traditional explanation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No compelling evidence exists to confirm the physical existence of Qi or the meridians. For Western acupuncturists, these points are instead sites at which nerves can be stimulated; thus, acupuncture is considered a method of stimulating nerves and muscles. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Scientific explanation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acupuncture may benefit patients with rheumatic conditions. However, no consensus exists as to what constitutes good acupuncture practice, and which acupuncture technique is best for which condition or for which patient is uncertain. Acupuncture is associated with a powerful placebo effect, and many trials are of poor in quality. (See",
"      <a class=\"local\" href=\"#H5067563\">",
"       'Clinical use'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Evidence of clinical efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Small benefits of uncertain clinical significance have been seen in comparison with various control interventions in patients with chronic pain, osteoarthritis, low back pain, and epicondylitis. Convincing evidence of benefit in rheumatoid arthritis and in myofascial pain is lacking, and results of trials are mixed. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Evidence of clinical efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Severe complications of acupuncture, such as infection or traumatic injury (eg, pneumothorax), are very rare. Mild",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      transient adverse effects, such as mild bleeding or aggravation of symptoms, occur in a minority of patients. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Evidence of safety'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are a few absolute or relative contraindications to the use of acupuncture. These include the following (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Contraindications'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Severe bleeding disorders are a contraindication for needle acupuncture.",
"     </li>",
"     <li>",
"      Pregnancy (first trimester) is regarded by some acupuncturists as a contraindication.",
"     </li>",
"     <li>",
"      The presence of a cardiac pacemaker is a contraindication for electrical stimulation.",
"     </li>",
"     <li>",
"      Indwelling needles should not be used in patients at risk from bacteremia, such as asplenic patients or those who may become neutropenic.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Filshie J, Cummings TM. Western medical acupuncture. In: Acupuncture: A Scientific Appraisal, Ernst E, White A (Eds), Butterworth-Heinemann, Oxford 1999. p.31.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/2\">",
"      Ernst E. Usage of complementary therapies in rheumatology: a systematic review. Clin Rheumatol 1998; 17:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/3\">",
"      Vickers A, Zollman C. ABC of complementary medicine. Acupuncture. BMJ 1999; 319:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/4\">",
"      Han JS, Terenius L. Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol 1982; 22:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/5\">",
"      Andersson S, Lundeberg T. Acupuncture--from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 1995; 45:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/6\">",
"      Goldman N, Chen M, Fujita T, et al. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci 2010; 13:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/7\">",
"      Ulett GA, Han S, Han JS. Electroacupuncture: mechanisms and clinical application. Biol Psychiatry 1998; 44:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/8\">",
"      Guowei L, Rongzhao L, Jingqiang X, et al. Role of peripheral afferent nerve fiber in acupuncture analgesia elicited by needling point zusanli. Sci Sin 1979; 22:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/9\">",
"      Beissner F, Henke C. Methodological problems in FMRI studies on acupuncture: a critical review with special emphasis on visual and auditory cortex activations. Evid Based Complement Alternat Med 2011; 2011:607637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/10\">",
"      Ernst E. An evidence-based approach to acupuncture. Acupunct Med 1999; 17:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/11\">",
"      Ernst E. Acupuncture--a critical analysis. J Intern Med 2006; 259:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/12\">",
"      Ernst E, Lee MS. Acupuncture for rheumatic conditions: an overview of systematic reviews. Rheumatology (Oxford) 2010; 49:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/13\">",
"      Ezzo J, Berman B, Hadhazy VA, et al. Is acupuncture effective for the treatment of chronic pain? A systematic review. Pain 2000; 86:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/14\">",
"      Selfe TK, Taylor AG. Acupuncture and osteoarthritis of the knee: a review of randomized, controlled trials. Fam Community Health 2008; 31:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/15\">",
"      Manheimer E, Linde K, Lao L, et al. Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med 2007; 146:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/16\">",
"      Kwon YD, Pittler MH, Ernst E. Acupuncture for peripheral joint osteoarthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2006; 45:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/17\">",
"      Suarez-Almazor ME, Looney C, Liu Y, et al. A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication. Arthritis Care Res (Hoboken) 2010; 62:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/18\">",
"      Fraenkel L. Unpacking the effects of acupuncture. Arthritis Care Res (Hoboken) 2010; 62:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/19\">",
"      Stener-Victorin E, Kruse-Smidje C, Jung K. Comparison between electro-acupuncture and hydrotherapy, both in combination with patient education and patient education alone, on the symptomatic treatment of osteoarthritis of the hip. Clin J Pain 2004; 20:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/20\">",
"      Weiner DK, Rudy TE, Morone N, et al. Efficacy of periosteal stimulation therapy for the treatment of osteoarthritis-associated chronic knee pain: an initial controlled clinical trial. J Am Geriatr Soc 2007; 55:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/21\">",
"      Man SC, Baragar FD. Preliminary clinical study of acupuncture in rheumatoid arthritis. J Rheumatol 1974; 1:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/22\">",
"      David J, Townsend S, Sathanathan R, et al. The effect of acupuncture on patients with rheumatoid arthritis: a randomized, placebo-controlled cross-over study. Rheumatology (Oxford) 1999; 38:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/23\">",
"      Lee MS, Shin BC, Ernst E. Acupuncture for rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2008; 47:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/24\">",
"      Mayhew E, Ernst E. Acupuncture for fibromyalgia--a systematic review of randomized clinical trials. Rheumatology (Oxford) 2007; 46:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/25\">",
"      Ernst E, Lee MS, Choi TY. Acupuncture: does it alleviate pain and are there serious risks? A review of reviews. Pain 2011; 152:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/26\">",
"      White AR, Ernst E. A systematic review of randomized controlled trials of acupuncture for neck pain. Rheumatology (Oxford) 1999; 38:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/27\">",
"      He D, Veiersted KB, H&oslash;stmark AT, Medb&oslash; JI. Effect of acupuncture treatment on chronic neck and shoulder pain in sedentary female workers: a 6-month and 3-year follow-up study. Pain 2004; 109:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/28\">",
"      White P, Lewith G, Prescott P, Conway J. Acupuncture versus placebo for the treatment of chronic mechanical neck pain: a randomized, controlled trial. Ann Intern Med 2004; 141:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/29\">",
"      Trinh KV, Graham N, Gross AR, et al. Acupuncture for neck disorders. Cochrane Database Syst Rev 2006; :CD004870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/30\">",
"      Trinh KV, Phillips SD, Ho E, Damsma K. Acupuncture for the alleviation of lateral epicondyle pain: a systematic review. Rheumatology (Oxford) 2004; 43:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/31\">",
"      Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 2001; 82:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/32\">",
"      Tough EA, White AR, Cummings TM, et al. Acupuncture and dry needling in the management of myofascial trigger point pain: a systematic review and meta-analysis of randomised controlled trials. Eur J Pain 2009; 13:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/33\">",
"      Derry CJ, Derry S, McQuay HJ, Moore RA. Systematic review of systematic reviews of acupuncture published 1996-2005. Clin Med 2006; 6:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/34\">",
"      Ernst E, White A. Life-threatening adverse reactions after acupuncture? A systematic review. Pain 1997; 71:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/35\">",
"      Ernst E, White AR. Prospective studies of the safety of acupuncture: a systematic review. Am J Med 2001; 110:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/36\">",
"      Melchart D, Weidenhammer W, Streng A, et al. Prospective investigation of adverse effects of acupuncture in 97 733 patients. Arch Intern Med 2004; 164:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/37\">",
"      Ernst E. Deaths after acupuncture: A systematic review. Int J Risk Safety 2010; 22:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/38\">",
"      White A, Hayhoe S, Hart A, et al. Survey of adverse events following acupuncture (SAFA): a prospective study of 32,000 consultations. Acupunct Med 2001; 19:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/39\">",
"      Macpherson H, Scullion A, Thomas KJ, Walters S. Patient reports of adverse events associated with acupuncture treatment: a prospective national survey. Qual Saf Health Care 2004; 13:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/40\">",
"      Jindal V, Ge A, Mansky PJ. Safety and efficacy of acupuncture in children: a review of the evidence. J Pediatr Hematol Oncol 2008; 30:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7607/abstract/41\">",
"      Peuker ET, White A, Ernst E, et al. Traumatic complications of acupuncture. Therapists need to know human anatomy. Arch Fam Med 1999; 8:553.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7980 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.69.132.100-BE5EBB4FC7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7607=[""].join("\n");
var outline_f7_27_7607=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5067580\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      AN ACUPUNCTURE VISIT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      POSSIBLE MECHANISMS OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Traditional explanation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Scientific explanation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5067563\">",
"      CLINICAL USE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EVIDENCE OF CLINICAL EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Chronic pain of any etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Fibromyalgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Low back pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Neck pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Epicondylitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Myofascial trigger point pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      EVIDENCE OF SAFETY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5067580\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7980\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7980|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/33/25116\" title=\"table 1\">",
"      Acupuncture adverse events",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28457?source=related_link\">",
"      Acupuncture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=related_link\">",
"      Epicondylitis (tennis and golf elbow)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14586?source=related_link\">",
"      Initial treatment of fibromyalgia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5786?source=related_link\">",
"      Treatment of fibromyalgia in adults not responsive to initial therapies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_27_7608="LS adult 45 yrs";
var content_f7_27_7608=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70014%7EONC%2F78530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70014%7EONC%2F78530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen sclerosus (LS) adult 45 yrs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 297px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    45-year-old woman with purpura from scratching plus loss of labia minora. The white areas of LS show a cellophane-like shiny surface.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD&nbsp;and Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Balanitis xerotica obliterans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7608=[""].join("\n");
var outline_f7_27_7608=null;
var title_f7_27_7609="Urinary tract injury in gynecologic surgery: Evaluation and management";
var content_f7_27_7609=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urinary tract injury in gynecologic surgery: Evaluation and management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7609/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7609/contributors\">",
"     Donna Gilmour, MD, FRCSC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7609/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7609/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7609/contributors\">",
"     Howard T Sharp, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7609/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7609/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/27/7609/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract injuries are reported in approximately 1 percent of women who undergo pelvic surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/1\">",
"     1",
"    </a>",
"    ]. Intraoperative discovery of injury permits prompt repair. Delayed diagnosis of urinary tract injuries is of greater concern, since they may result in genitourinary fistula formation or severe renal complications.",
"   </p>",
"   <p>",
"    The evaluation and management of urinary tract injury in gynecologic surgery are reviewed here. Prevention of urinary tract injury, urinary tract injuries during advanced procedures performed for urinary incontinence, pelvic organ prolapse, or gynecologic malignancy, as well as during obstetric procedures, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14730?source=see_link\">",
"     \"Radical hysterectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/21/14682?source=see_link\">",
"     \"Cesarean delivery: Technique\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/39/15994?source=see_link\">",
"     \"Operative vaginal delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INTRAOPERATIVE EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Screening for injury with cystoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The routine intraoperative use of cystoscopy for women undergoing major gynecologic surgery has been proposed as a secondary preventive measure for urinary tract injury [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Cystoscopy detects a greater proportion of injuries than visual inspection of the urinary tract. Visual inspection detects a greater proportion of bladder injuries than ureteral injuries. This was illustrated in two prospective series of hysterectomy (abdominal, vaginal, or laparoscopic) in which cystoscopy was used routinely (n = 839 and 471) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Visual inspection of the urinary tract injury failed to detect 87 to 93 percent (7 of 8 and 14 of 15) of ureteral injuries and 62 to 65 percent of bladder injuries (15 of 24 and 11 of 17) that were subsequently diagnosed with cystoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Only one injury in each series was not detected by either visual inspection or cystoscopy and each of these women presented postoperatively with a genitourinary fistula.",
"   </p>",
"   <p>",
"    Cystoscopy detects injuries that require repair, as well as others that would likely not result in clinical consequences (eg, a transmural bladder suture that would absorb if not removed). Despite the potential for overdetection, however, it appears that most injuries detected by routine cystoscopy are clinically significant. In the prospective studies described in the preceding paragraph, the majority of ureteral injuries (nearly all of which were detected solely by cystoscopy) were likely to require repair rather than heal spontaneously (transection, crush injury, ligation: 9 of 15 and 7 of 8 versus kinking: 6 of 15 and 1 of 8). Only one of the studies specified which bladder injuries were detected solely by cystoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/4\">",
"     4",
"    </a>",
"    ]. The majority of these injuries were also likely to require versus not require treatment (cystotomy: 9 of 11 versus abrasion or transmural suture: 2 of 11). All five of the bladder injuries detected by cystoscopy were cystotomies, rather than more subtle injuries.",
"   </p>",
"   <p>",
"    When routine intraoperative cystoscopy is used, it appears that there is a reduced rate of urinary tract injuries discovered postoperatively. A systematic review of 47 retrospective studies of gynecologic surgery evaluated the effect on diagnosis of urinary tract injury with routine use of intraoperative cystoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/1\">",
"     1",
"    </a>",
"    ]. The rate of urinary tract injury diagnosed postoperatively was lower in studies with versus without routine cystoscopy: bladder injury (0.8 versus 2.2 per 1000 procedures) and ureteral injury (1.0 versus 2.2 per 1000). This rate combines data for several types of procedures (eg, hysterectomy, prolapse repair), which may obscure procedure-specific differences. This analysis was also limited by the use of retrospective data, which may have omitted complications (eg, patients who presented to other institutions).",
"   </p>",
"   <p>",
"    Cystoscopy rarely results in complications. Most gynecologists are not trained to perform cystoscopy, but it is easily learned. Thus, the disadvantage of performing cystoscopy in all women who undergo major gynecologic surgery is expense. This includes the cost of training gynecologists to perform cystoscopy, additional operating room time, and costs incurred by evaluation or treatment of injuries that would have healed spontaneously or other incidentally noted conditions (eg, congenital anomalies) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/57/29592?source=see_link\">",
"     \"Diagnostic cystourethroscopy for gynecologic conditions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no high quality data regarding the cost-effectiveness of routine use of cystoscopy. The one study that analyzed the cost-effectiveness of routine cystoscopy for total abdominal hysterectomy reported that, at a baseline ureteral injury rate of 15 per 1000, the additional cost of routine intraoperative cystoscopy was equal to the cost resulting from injuries missed because cystoscopy was not performed (eg, surgical repair) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/6\">",
"     6",
"    </a>",
"    ]. However, this analysis was based on a false assumption that intraoperative cystoscopy has 100 percent sensitivity and specificity and that all injuries detected would require surgical repair. Also, costs for procedures vary across institutions and countries, and thus the feasibility of routine cystoscopy will differ by setting.",
"   </p>",
"   <p>",
"    In summary, use of routine cystoscopy compared with visual inspection after major gynecologic surgery results in the detection of more urinary tract injuries, particularly ureteral injuries. It appears that routine cystoscopy results in fewer delayed diagnoses of injury. Cystoscopy is a simple procedure with a low risk of complications. However, lack of training of gynecologists in this technique is a barrier to wider implementation.",
"   </p>",
"   <p>",
"    The American College of Obstetricians and Gynecologists has advised that cystoscopy should be performed intraoperatively to assess for bladder or ureteral damage after all prolapse or incontinence procedures during which the bladder or ureters may be at risk of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. We suggest routine intraoperative use of cystoscopy in addition to visual inspection of the urinary tract rather than visual inspection alone for women undergoing surgical treatment of urinary incontinence or anterior or apical pelvic organ prolapse. For women undergoing hysterectomy or those undergoing oophorectomy who have risk factors for ureteral injury (eg, endometriosis, history of pelvic irradiation), we suggest routine intraoperative cystoscopy be performed if the operating surgeon is trained in the use of cystoscopy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link&amp;anchor=H2#H2\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\", section on 'Incidence'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link&amp;anchor=H5#H5\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Findings suggestive of injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;When there is a finding suggestive of injury, intraoperative evaluation is initiated. In some cases, a defect can be seen grossly after a laceration or transection of a ureter or a cystotomy. A cystotomy may be recognized if the bladder catheter is seen in the operative field or the bladder mucosa is visualized. Injury may also be suspected if the ureter is noted in close proximity to a clamp, suture, or staple.",
"   </p>",
"   <p>",
"    The appearance of urine in the operative field also alerts the surgeon to the presence of injury. In addition, the appearance of blood in the urine output from the bladder catheter may signify injury. Ongoing hematuria is more suggestive of injury than blood which clears rapidly. Transient bleeding may result from minor trauma during urinary tract manipulation (eg, insertion of the bladder catheter, pressure from retractor) and should be observed until the blood clears. If hematuria persists, further evaluation should be performed. In laparoscopic surgery, gas may be visible in the bladder catheter output if injury has occurred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Inspection of the urinary tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;When using an abdominal or laparoscopic surgical approach, the first step in the evaluation of suspected injury is visual inspection to assess the integrity of the bladder and ureters and the nature and severity of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/2\">",
"     2",
"    </a>",
"    ]. It is important to inspect all urinary tract structures, since if a ureter has been injured, the contralateral ureter or bladder may also have been injured. Bladder injury is more likely than ureteral injury to be diagnosed using visual inspection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/1,3,5,9\">",
"     1,3,5,9",
"    </a>",
"    ]. In a prospective study on 839 women who underwent hysterectomy, visual inspection detected 9 of 24 bladder injuries (38 percent) versus 1 of 15 ureteral injuries (7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Observing the ureter for peristalsis is used to identify the ureter, but it is not a valid test for ureteral integrity. In a prospective study in which women undergoing total abdominal hysterectomy were evaluated with intraoperative cystoscopy, peristalsis was present in five of six women with ureteral injury [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/9\">",
"     9",
"    </a>",
"    ]. Full evaluation of a ureter may require further dissection of the ureter, if the ureter has not been fully isolated. Whether to perform this ureteral dissection initially or defer dissection and evaluate the urinary tract integrity at a later time during surgery (eg, with cystoscopy) is based upon the surgeon's preference and skills.",
"   </p>",
"   <p>",
"    During vaginal surgery, all pedicles and the anterior vaginal wall should be inspected for possible areas of impingement upon urinary tract structures. It is not possible to inspect the bladder or ureters directly when using a vaginal approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Intravesical or intravenous dye",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of agents that color the urine can be used as a rapid test of the integrity of the lower urinary tract.",
"   </p>",
"   <p>",
"    Leakage of dye into the operative field confirms the presence of a bladder or ureteral defect and helps to pinpoint its location. The absence of the appearance of dye does not exclude injury since dye may be sequestered (eg, in the retroperitoneum) or an injury other than a laceration may have occurred. Also, if free spillage of dye into the operative site occurs and the precise source is uncertain, further dissection or evaluation to fully inspect the bladder and ureters is necessary. The technique for dissection of the ureters and bladders is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link&amp;anchor=H23#H23\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\", section on 'Operative technique'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Urinary dye can be administered through either of two routes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intravesical &mdash; A dye is instilled into the bladder through the bladder catheter; options include 200 to 500 mL of either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      (two to three drops in saline) or sterile infant formula (commonly available in obstetric operating rooms; no dilution required) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. Intravesical dye is primarily for suspected bladder injury; ureteral injuries distal from the bladder may not be revealed.",
"     </li>",
"     <li>",
"      Intravenous &mdash;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"       Indigo carmine",
"      </a>",
"      (2.5 mL of a 0.8 percent solution) is administered intravenously. Administration of a fluid bolus or placing the patient in reverse Trendelenburg position speeds the flow of dye; a diuretic (eg, intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      20 mg) may be used in patients who have no renal compromise.",
"      <br/>",
"      <br/>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       Methylene blue",
"      </a>",
"      is not used intravenously for this purpose because a cumulative dose &gt;7",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      can result in methemoglobinemia in susceptible individuals. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Following intravenous administration, the indigo carmine dye should pass into the output of the bladder catheter, in addition to being visible in the operative field if a defect is present. Output of blue urine signifies only that at least one ureter is functioning; the other ureter may have been injured. Failure to visualize blue urine in the output of the bladder catheter after administering indigo carmine suggests occlusion of both ureters.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cystoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;To evaluate for urinary tract injury with cystoscopy, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     indigo carmine",
"    </a>",
"    is administered, as described in the preceding section. The bladder is inspected for injury (eg, perforation, bleeding, a transmural suture or staple). The ureteral orifices are observed for efflux of blue dye. Absence or abnormal flow (delayed or sluggish) from one or both ureters warrants further evaluation for ureteral transection or obstruction. The procedure of cystoscopy is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/57/29592?source=see_link\">",
"     \"Diagnostic cystourethroscopy for gynecologic conditions\"",
"    </a>",
"    .) Circumstances may arise where a patient undergoing an open procedure in the dorsal supine position is considered at risk for bladder or ureteral injury and cystoscopy is considered. While one option is to re-position and drape the patient in lithotomy position and then proceed, there are other possibilities. A 70 or 30 degree cystoscope can be placed through the dome of the bladder in the operative field and the opening tied with a purse-string suture; or, a simple incision can be made into the dome of the bladder and direct inspection carried out. Another option is to position patients in the dorsal lithotomy position before abdominal surgery and use lithotomy stirrups that can adjust from a low to high position plus a self-retaining retractor that does not interfere with elevating the upper thigh. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link&amp;anchor=H19#H19\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\", section on 'Operative set-up'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link&amp;anchor=H20#H20\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\", section on 'Patient positioning'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ureterography",
"    </span>",
"    &nbsp;&mdash;&nbsp;A ureteral defect can be diagnosed with intraoperative contrast studies (eg, retrograde ureterography or intravenous pyelography). Extravasation of contrast confirms a ureteral defect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE RECOGNITION OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important principle of postoperative diagnosis of urinary tract injury is to have a high index of suspicion, since early symptoms and signs may be subtle. Any suspicion of injury should be promptly investigated. Early diagnosis facilitates management of the injury and speeds recovery.",
"   </p>",
"   <p>",
"    Urinary tract injuries are usually distressing for patients. The attending gynecologic surgeon should stay involved with the patient's care, assisting with explaining upcoming procedures, test results, and providing the patient opportunity to ask about the details and circumstances around the intraoperative injury, even when the patient is referred for surgical repair by another surgeon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presentation of a urinary tract injury after gynecologic surgery depends upon the underlying pathology and how much time has passed since surgery.",
"   </p>",
"   <p>",
"    Urinary tract injuries that are not recognized intraoperatively are most likely to present within the first two weeks after surgery, but some cases present later. Gynecologic surgeons need to ensure that these early presentations, often with subtle symptoms and signs, are recognized, thereby allowing diagnosis and management. As an example, in a series of 20 urinary tract injuries in women after pelvic surgery, the mean time to diagnosis was 5.6 days (range 0 to 14 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/12\">",
"     12",
"    </a>",
"    ]. During the first 14 days after surgery, signs and symptoms that should prompt evaluation for urinary tract injury include [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/2,13\">",
"     2,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Leakage of urine from the vagina or abdominal incision",
"     </li>",
"     <li>",
"      Unilateral or bilateral flank pain",
"     </li>",
"     <li>",
"      Hematuria",
"     </li>",
"     <li>",
"      Oliguria",
"     </li>",
"     <li>",
"      Anuria",
"     </li>",
"     <li>",
"      Abdominal pain or distension",
"     </li>",
"     <li>",
"      Nausea with or without vomiting",
"     </li>",
"     <li>",
"      Ileus",
"     </li>",
"     <li>",
"      Fever",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Symptoms coincide with the location and type of injury. Obstruction or laceration of the urinary tract are the most common mechanisms of injury. A combination of obstruction and a laceration in the urinary tract may present with a combination of signs and symptoms. There can also be more than one area injured, including a combination of ureteral and bladder injuries. Coincident urinary tract infection often increases the acuity of the presentation and the severity of illness. Intraperitoneal leakage of infected urine or a combination of urinary tract obstruction and infection can lead to severe and quick compromise in a previously healthy adult.",
"   </p>",
"   <p>",
"    Complete ureteral obstruction may present with ipsilateral flank pain within 24 hours after surgery. However, many patients may present with pain in other locations or may be asymptomatic. Postoperative analgesics may also mask the pain. Due to these variations in the presentation, clinicians should be vigilant regarding symptoms that suggest ureteral obstruction. Stasis of urine can predispose to pyelonephritis. Partial ureteral obstruction may be asymptomatic, but may progress over time to complete obstruction and result in loss of function in the ipsilateral kidney. Such loss of function may remain silent or be discovered at some point during investigations for other health conditions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=see_link\">",
"     \"Diagnosis of urinary tract obstruction and hydronephrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A ureteral or bladder defect with leakage of urine into the peritoneal cavity may present as abdominal pain and ascites. Peritonitis may develop and irritation of the bowel from the urine usually results in ileus. Leakage of urine from the vagina or abdominal incision in the immediate postoperative period after hysterectomy is likely due to drainage of a peritoneal collection of urine. The timecourse of development of vesicovaginal or ureteral vaginal fistula ranges from days to weeks. Copious serosanguinous drainage from an incision may also signify wound dehiscence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21113?source=see_link&amp;anchor=H11#H11\">",
"     \"Abdominal surgical incisions: Prevention and treatment of complications\", section on 'Fascial dehiscence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the retroperitoneum, a collection may develop into a urinoma; the patient may become febrile due to infection and inflammation associated with this process. Based on the urinary tract anatomy, a retroperitoneal collection is typically due to a ureteral, rather than bladder injury.",
"   </p>",
"   <p>",
"    Hematuria may be apparent immediately after the bladder catheter is removed, but this should clear shortly after removal. If bleeding persists or appears remote from the removal of the catheter, urinary tract injury should be suspected. Anuria signifies bilateral ureteral obstruction or transection or other structural or intrinsic renal process (eg, renal failure) and requires immediate evaluation. Oliguria can occur in the setting of ureteral obstruction, but it is not a specific sign because there are other postoperative causes for oliguria after surgery (eg, fluid shifts to the interstitial space).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Postoperative evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of postoperative urinary tract injury is made using cystoscopy or imaging studies of the urinary tract. The patient's symptoms and results of physical examination and laboratory studies also contribute to the choice of diagnostic study and identification of other complications associated with the injury (eg, renal insufficiency, urinary tract infection).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vital signs are taken to assess hemodynamic stability and whether the patient is febrile. The urine output for the previous 24-hour period is calculated and the urine inspected for hematuria. The abdomen is assessed for signs of peritonitis, ascites, and the presence of bowel sounds. Following abdominal surgery, the integrity of the abdominal incision(s) is evaluated. A pelvic examination is conducted to rule out a pelvic mass or tenderness and leakage of urine from the vaginal incision(s). The back is examined for costovertebral tenderness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum electrolytes, blood urea nitrogen (BUN), and creatinine are measured.",
"   </p>",
"   <p>",
"    Bilateral ureteral obstruction results in acute renal failure (acute kidney injury). Unilateral complete obstruction is accompanied by a transient minimal increase in creatinine as the other kidney compensates for the loss of function in the contralateral kidney. A case control study of 15 women with unilateral ureteral obstruction after gynecologic surgery reported that the increase in creatine from the postoperative value was significantly higher in women with obstruction compared with age- and procedure-matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/14\">",
"     14",
"    </a>",
"    ]. For the women with ureteral obstruction, at 36 to 48 hours after surgery, the mean increase from the preoperative creatine was 0.8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    above the preoperative value (range for women with obstruction: 0.3 to 1.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    versus controls: -0.2 to 0.3",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"   </p>",
"   <p>",
"    Urinalysis is sent to assess for infection and hematuria, a urine culture is sent if the results suggest infection. Alternatively, a urine culture can be sent without obtaining a urinalysis if the patient is at high risk of infection or if infection is suspected. Urine culture is sent.",
"   </p>",
"   <p>",
"    If urinary ascites is suspected, some clinicians obtain a biochemical analysis of the peritoneal fluid by performing paracentesis or sending fluid from an intraperitoneal drain (eg, Jackson-Pratt drain). The results from such testing do not provide direct evidence of urinary tract injury, and confirmation may still be needed with more definitive testing (eg, cystoscopy with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     indigo carmine",
"    </a>",
"    , imaging studies).",
"   </p>",
"   <p>",
"    Evidence regarding the diagnosis of urinary ascites is limited to case reports and small case series. As an example, a case series of women in the postoperative period following radical hysterectomy reported mean normal values for urea nitrogen (peritoneal: 10",
"    <span class=\"nowrap\">",
"     mg/dL;",
"    </span>",
"    urine: 469",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    and creatine (peritoneal: 0.9",
"    <span class=\"nowrap\">",
"     mg/dL;",
"    </span>",
"    urine: 141",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/15\">",
"     15",
"    </a>",
"    ]. In contrast, in patients with liver cirrhosis, BUN and creatinine concentrations are similar in ascites and serum [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/16\">",
"     16",
"    </a>",
"    ]. The values for urinary ascites will be similar to urine rather than serum (or peritoneal fluid, which has values similar to serum) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/15,17,18\">",
"     15,17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If peritoneal fluid is sent for biochemical analysis, the BUN and creatinine of the peritoneal fluid is measured and compared to the patient&rsquo;s serum and urine levels. The results are interpreted as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A finding of similar values in serum and ascitic fluid (or lower levels in ascitic fluid) is reassuring for the absence of urinary ascites. However, the patient should be evaluated further if urinary tract injury is still suspected. In addition, if significant non-urine ascites is present, the patient may need to be further evaluated for other etiologies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/43/14010?source=see_link\">",
"       \"Evaluation of adults with ascites\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If BUN and creatinine are normal in the serum and elevated to a level similar to urine in the ascitic fluid, urinary tract injury is likely, but requires testing with cystoscopy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      imaging for confirmation.",
"     </li>",
"     <li>",
"      If the values are elevated in both serum and ascitic fluid, this may represent both acute renal failure and urinary ascites possibly from urinary tract injury. This result warrants further evaluation of renal function and cystoscopy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      imaging to further evaluate for urinary tract injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=see_link\">",
"       \"Assessment of kidney function\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Cystoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystoscopy is performed to assess for bladder injury and evaluate ureteral function (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Cystoscopy'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder injury can be evaluated with a cystogram if cystoscopy cannot be performed; however, a cystogram can detect a laceration or large foreign body, but not more subtle findings (eg, a transmural suture or attenuation of the bladder mucosa) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. When ureteral injury is suspected, ultrasonography can be helpful as an initial test to assess for hydronephrosis or to exclude a retroperitoneal collection. We follow this with computed tomography with renal contrast or cystoscopy with retrograde intravenous pyelography, depending on test availability.",
"   </p>",
"   <p>",
"    Once a diagnosis of ureteral injury is suspected or confirmed, a retrograde pyelogram can give more information regarding the precise location of the injury. There is debate regarding whether stent placement should be attempted at the time of a retrograde pyelogram. Dowling and associates found that, in 19 of 20 patients, a retrograde stent could not be placed beyond the site of the urological injury [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/19\">",
"     19",
"    </a>",
"    ]. However, others feel that if a stent can be negotiated through the area of injury, in some cases, this will promote satisfactory ureteral healing and avoid the need for open surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/21\">",
"     21",
"    </a>",
"    ]. A stent may be helpful in cases of ureteral injury without obstruction, such as small perforations, thermal injury, or short segments of devascularization.",
"   </p>",
"   <p>",
"    If a retroperitoneal, pelvic, or abdominal urinoma is suspected, ultrasonography is the initial imaging study of choice. Further clarification of the location of a fluid collection can be evaluated with computed tomography or magnetic resonance imaging.",
"   </p>",
"   <p>",
"    Evaluation of patients with urinary tract obstruction or genitourinary fistula is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=see_link\">",
"     \"Diagnosis of urinary tract obstruction and hydronephrosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44792?source=see_link&amp;anchor=H4#H4\">",
"     \"Urogenital tract fistulas in women\", section on 'Cystoscopy and imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Intraoperative versus postoperative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract injury recognized during surgery should be treated intraoperatively rather than delaying until after surgery or performing a second procedure.",
"   </p>",
"   <p>",
"    Upon postoperative diagnosis of a urinary tract injury, the first priorities are to relieve renal obstruction, treat infection and stop urine leakage. In some cases, obstruction or leakage can be managed with ureteral stents, a minimally invasive procedure. Otherwise, surgical exploration is required for repair of the injury. If definitive repair must be delayed, temporary measures (eg, nephrostomy) may be necessary. Ureteral stenting and surgical repair of the urinary tract should be performed by a surgeon with experience with these procedures, often a urologist or urogynecologist. Repair of genitourinary fistula is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44792?source=see_link&amp;anchor=H7#H7\">",
"     \"Urogenital tract fistulas in women\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5748302\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most surgeons do not administer additional antibiotic prophylaxis when a urinary tract injury occurs, whether it is recognized intra- or postoperatively. Urinary tract injury is most likely to occur in major gynecologic procedures for which routinely used antibiotic prophylactic agents (cephalosporins,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    , or fluoroquinolones) (",
"    <a class=\"graphic graphic_table graphicRef87199 \" href=\"UTD.htm?0/45/733\">",
"     table 1",
"    </a>",
"    ) cover the enteric gram-negative bacilli that comprise most urinary tract pathogens. There are no high quality data that address this issue. In our practice, if a patient in whom a urinary tract injury occurs has clinical signs suggestive of a urinary tract infection (cloudy urine output from the bladder catheter, malodorous urine, or bladder mucosa that appears inflamed on cystoscopy), we send urine culture during surgery and treat empirically for a urinary tract infection until the culture results are received.",
"   </p>",
"   <p>",
"    A bladder catheter is used for several days or weeks in many women following a urinary tract injury. Based upon high quality data, prophylactic antibiotics to prevent urinary tract infection are not required in this setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=see_link&amp;anchor=H11#H11\">",
"     \"Urinary tract infection associated with urethral catheters\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ureteral injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repair of ureteral injuries often involves ureteral stenting or advanced surgical repair.",
"   </p>",
"   <p>",
"    The exception to this is the ligation or kinking of a ureter with a suture. In such cases, the suture is removed and the integrity of the ureter is inspected. Cystoscopy is performed to verify ureteral function. If the efflux from the ureter is absent or abnormal, a surgeon with experience with urinary tract injury, typically a urologist or urogynecologist, should be consulted intraoperatively. If there is doubt regarding the integrity of the ureter, a ureteral stent may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15242?source=see_link\">",
"     \"Placement and management of indwelling ureteral stents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/40/43655?source=see_link\">",
"     \"Surgical repair of an iatrogenic ureteral injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Injuries such as transection or other types of extensive damage (eg, crush injury, thermal damage) may require reanastomosis or ureteroneocystostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/22\">",
"     22",
"    </a>",
"    ]. Repair of such injures is usually performed by a urologist or other surgical specialist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/40/43655?source=see_link\">",
"     \"Surgical repair of an iatrogenic ureteral injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bladder injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to repair of a bladder injury depends upon the site, type, and severity of injury. Potential sites of injury to the bladder include the dome, supratrigonal area, trigone, and below the trigone.",
"   </p>",
"   <p>",
"    Treatment of thermal bladder injury varies depending upon the extent of injury. This type of injury should be managed by a clinician experienced with thermal urinary tract injury, typically a urologist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Bladder dome",
"    </span>",
"    &nbsp;&mdash;&nbsp;When recognized intraoperatively, dome or supratrigonal injuries are usually repaired with excellent results. Delayed identification and repair of injury to the bladder dome are more difficult.",
"   </p>",
"   <p>",
"    If the injury noted is an accidentally placed suture or staple, the foreign material is removed. The bladder should then be re-inspected after removal to confirm no tear has occurred. Similarly, mesh tapes may be inadvertently inserted into the bladder.",
"   </p>",
"   <p>",
"    Repair of cystotomy limited to this area of the bladder is a straightforward procedure in most patients, but should only be performed by a surgeon with experience with this type of repair. Bladder injury in women in whom primary closure is difficult (eg, vaginal surgery or history of pelvic irradiation) or which is not a simple cystotomy requires intraoperative consultation with an advanced gynecologic or urologic surgeon with skills in these more complicated repairs.",
"   </p>",
"   <p>",
"    Management of a cystotomy in the bladder dome depends upon the size of the defect. Minimal defects in the bladder dome (eg, a &lt;2 mm injury from pneumoperitoneum needle during laparoscopic surgery) can be managed expectantly. Very small injuries (eg, &lt;1 cm) may either be repaired or managed by leaving the bladder catheter in place for five to seven days, followed by a cystogram to confirm closure. All other cystotomies should be repaired.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      How to perform a cystotomy repair &mdash; The repair should be delayed until all other surgical dissection is completed, since other injuries may occur. The repair is a one- or two-layered running closure with absorbable suture. We use an absorbable synthetic suture (eg, Monocryl&trade;, Vicryl&trade;). We use one layer for a small cystotomy (eg, &lt;2 cm) or two layers for larger cystotomies. When there are more than one cystostomy in close proximity to each other and well away from the bladder trigone, an option is to incise the small defects to combine them into a single defect before beginning the repair. When the repair is completed, the closure should be tested to see if it is water-tight by instilling dye into the bladder catheter (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Intravesical or intravenous dye'",
"      </a>",
"      above).",
"      <br/>",
"      <br/>",
"      The bladder will reepithelialize within three to four days and regains its normal strength after 21 days [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/23-25\">",
"       23-25",
"      </a>",
"      ]. We usually leave the bladder catheter in for 5 to 14 days, depending on the size and location of the defect. We obtain a cystogram to confirm the injury has healed before removing the catheter, especially for larger cystotomies. Prophylactic antibiotics are not required for these women (See",
"      <a class=\"local\" href=\"#H5748302\">",
"       'Antibiotic prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Bladder trigone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries to the trigone or below the trigone may involve the ureters or urethra and are more difficult to repair than dome or supratrigonal injuries. Exposure and suturing of this area are difficult, particularly during abdominal or laparoscopic procedures. This is because the trigone includes the ostia of the ureters and urethra and is located in the inferior and posterior aspect of the bladder.",
"   </p>",
"   <p>",
"    When an injury to the trigone occurs, the integrity of the ureters and urethra must be assessed. Ureteral stent placement may be required. Repair of the bladder defect and other injuries must be performed by an advanced gynecologic or urologic surgeon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Neurogenic bladder dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative bladder dysfunction is a common complication of gynecologic surgery. In a prospective series of 284 women who underwent gynecologic surgery, the incidence of postoperative urinary retention was 9 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/26\">",
"     26",
"    </a>",
"    ]. Women with postoperative urinary retention are treated with bladder catheterization. In our experience, normal bladder function will return within several days in most patients.",
"   </p>",
"   <p>",
"    Chronic postoperative neurogenic bladder dysfunction usually results from procedures that involve extensive dissection and mobilization of the bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7609/abstract/27\">",
"     27",
"    </a>",
"    ]. This type of complication is more likely following extensive perivesical dissection. Radical hysterectomy, for example, interrupts parasympathetic and sympathetic innervation due to resection of the uterosacral and cardinal ligaments. Operative trauma may result in edema and hematoma formation that affects the bladder's functions of urine collection and micturition.",
"   </p>",
"   <p>",
"    Management of neurogenic bladder dysfunction is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35912?source=see_link\">",
"     \"Acute urinary retention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Urethral injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral injury following pelvic surgery most commonly occurs during surgery for pelvic organ prolapse or urinary incontinence. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33562?source=see_link&amp;anchor=H4701082#H4701082\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Urethral injury'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33401?source=see_link&amp;anchor=H492568#H492568\">",
"     \"Stress urinary incontinence in women: Transobturator midurethral slings\", section on 'Bladder or urethral injury'",
"    </a>",
"    .) Urethrovaginal fistula is most commonly associated with anterior colporrhaphy or obstetric forceps rotations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44792?source=see_link&amp;anchor=H20#H20\">",
"     \"Urogenital tract fistulas in women\", section on 'Urethrovaginal fistulas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intraoperative discovery of urinary tract injury during gynecologic surgery permits prompt repair. Delayed diagnosis of urinary tract injuries is of greater concern, since they may result in genitourinary fistula formation or severe renal complications. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urinary tract injury may be seen grossly during surgery or may be suspected if the ureter or bladder are noted in close proximity to a clamp, suture, or staple, or if urine or the bladder catheter are seen in the operative field. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Findings suggestive of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Methods for intraoperative assessment for urinary tract injury include visual inspection, cystoscopy, and ureterography. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Intraoperative evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest routine intraoperative use of cystoscopy in addition to visual inspection of the urinary tract rather than visual inspection alone for women undergoing surgical treatment of urinary incontinence or anterior or apical pelvic organ prolapse (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Routine intraoperative cystoscopy is also an option for women undergoing hysterectomy or those undergoing oophorectomy who have risk factors for ureteral injury (eg, endometriosis, history of pelvic irradiation). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Screening for injury with cystoscopy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link&amp;anchor=H2#H2\">",
"       \"Urinary tract injury in gynecologic surgery: Prevention\", section on 'Incidence'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link&amp;anchor=H5#H5\">",
"       \"Urinary tract injury in gynecologic surgery: Prevention\", section on 'Risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Signs and symptoms of urinary tract injury during the first two weeks after surgery may include: leakage of urine from the vagina or abdominal incision, flank pain, hematuria, oliguria, anuria, abdominal pain or distension, nausea, vomiting, ileus, and fever. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obstruction or laceration of the urinary tract are the most common mechanisms of injury. More than one injury may be present, including a combination of obstruction and laceration. Coincident urinary tract infection often increases the acuity of the presentation and the severity of illness. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of postoperative urinary tract injury is made using cystoscopy or imaging studies of the urinary tract. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Postoperative evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urinary tract injury recognized during surgery is best treated intraoperatively. Upon postoperative diagnosis of an injury, the first priorities are to treat infection, relieve renal obstruction, and stop urine leakage. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Intraoperative versus postoperative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Repair of ureteral injuries often involves ureteral stenting or advanced surgical repair, including ureteral reanastomosis or ureteroneocystostomy. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Ureteral injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to repair of a bladder injury depends upon the site, type, and severity of injury. Injuries to the trigone are the most difficult to repair. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Bladder injury'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/1\">",
"      Gilmour DT, Das S, Flowerdew G. Rates of urinary tract injury from gynecologic surgery and the role of intraoperative cystoscopy. Obstet Gynecol 2006; 107:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/2\">",
"      Chan JK, Morrow J, Manetta A. Prevention of ureteral injuries in gynecologic surgery. Am J Obstet Gynecol 2003; 188:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/3\">",
"      Ibeanu OA, Chesson RR, Echols KT, et al. Urinary tract injury during hysterectomy based on universal cystoscopy. Obstet Gynecol 2009; 113:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/4\">",
"      Vakili B, Chesson RR, Kyle BL, et al. The incidence of urinary tract injury during hysterectomy: a prospective analysis based on universal cystoscopy. Am J Obstet Gynecol 2005; 192:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/5\">",
"      Jelovsek JE, Chiung C, Chen G, et al. Incidence of lower urinary tract injury at the time of total laparoscopic hysterectomy. JSLS 2007; 11:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/6\">",
"      Visco AG, Taber KH, Weidner AC, et al. Cost-effectiveness of universal cystoscopy to identify ureteral injury at hysterectomy. Obstet Gynecol 2001; 97:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/7\">",
"      ACOG Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin No. 85: Pelvic organ prolapse. Obstet Gynecol 2007; 110:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/8\">",
"      American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Number 372. July 2007. The Role of cystourethroscopy in the generalist obstetrician-gynecologist practice. Obstet Gynecol 2007; 110:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/9\">",
"      Gilmour DT, Baskett TF. Disability and litigation from urinary tract injuries at benign gynecologic surgery in Canada. Obstet Gynecol 2005; 105:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/10\">",
"      Buchsbaum GM, Moll C, Duecy EE. True occult bladder perforation during placement of tension-free vaginal tape. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/11\">",
"      Labin LC, Morse AN, Young SB. Vaginal revision of intravesical tension-free vaginal tape 44 h after initial placement: a case report. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/12\">",
"      Meirow D, Moriel EZ, Zilberman M, Farkas A. Evaluation and treatment of iatrogenic ureteral injuries during obstetric and gynecologic operations for nonmalignant conditions. J Am Coll Surg 1994; 178:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/13\">",
"      Sorinola O, Begum R. Prevention and management of ureteric injuries. Hosp Med 2005; 66:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/14\">",
"      Stanhope CR, Wilson TO, Utz WJ, et al. Suture entrapment and secondary ureteral obstruction. Am J Obstet Gynecol 1991; 164:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/15\">",
"      Manahan KJ, Fanning J. Peritoneal fluid urea nitrogen and creatinine reference values. Obstet Gynecol 1999; 93:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/16\">",
"      Nguyen-Khac E, Thevenot T, Capron D, et al. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood. Eur J Intern Med 2008; 19:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/17\">",
"      Wong MH, Lim SK, Ng KL, Ng KP. Pseudo-acute kidney injury with recurrent ascites due to intraperitoneal urine leakage. Intern Med J 2012; 42:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/18\">",
"      Charalampidis S, Petrides C, Charalampous C, Stavrou S. Hyponatremic renal pseudofailure and massive ascites following normal vaginal delivery: a diagnostic and therapeutic challenge. Ren Fail 2012; 34:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/19\">",
"      Dowling RA, Corriere JN Jr, Sandler CM. Iatrogenic ureteral injury. J Urol 1986; 135:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/20\">",
"      Mann WJ. Intentional and unintentional ureteral surgical treatment in gynecologic procedures. Surg Gynecol Obstet 1991; 172:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/21\">",
"      Mitty HA, Train JS, Dan SJ. Antegrade ureteral stenting in the management of fistulas, strictures, and calculi. Radiology 1983; 149:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/22\">",
"      Kim JH, Moore C, Jones JS, et al. Management of ureteral injuries associated with vaginal surgery for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/23\">",
"      Hastings JC, Van Winkle W, Barker E, et al. The effect of suture materials on healing wounds of the bladder. Surg Gynecol Obstet 1975; 140:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/24\">",
"      Hanke PR, Timm P, Falk G, Kramer W. Behavior of different suture materials in the urinary bladder of the rabbit with special reference to wound healing, epithelization and crystallization. Urol Int 1994; 52:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/25\">",
"      Hepperlen TW, Stinson W, Hutson J, Bartone FF. Epithelialization after cystotomy. Invest Urol 1975; 12:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/26\">",
"      B&oslash;dker B, Lose G. Postoperative urinary retention in gynecologic patients. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7609/abstract/27\">",
"      Al-Took S, Platt R, Tulandi T. Adhesion-related small-bowel obstruction after gynecologic operations. Am J Obstet Gynecol 1999; 180:313.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3276 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-1420615FBC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7609=[""].join("\n");
var outline_f7_27_7609=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INTRAOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Screening for injury with cystoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Findings suggestive of injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Inspection of the urinary tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Intravesical or intravenous dye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cystoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ureterography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      POSTOPERATIVE RECOGNITION OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Postoperative evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Cystoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Intraoperative versus postoperative management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5748302\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ureteral injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bladder injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Bladder dome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Bladder trigone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Neurogenic bladder dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Urethral injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3276\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3276|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/45/733\" title=\"table 1\">",
"      Antimicrobial prophylaxis for genitourinary surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21113?source=related_link\">",
"      Abdominal surgical incisions: Prevention and treatment of complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35912?source=related_link\">",
"      Acute urinary retention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=related_link\">",
"      Assessment of kidney function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/21/14682?source=related_link\">",
"      Cesarean delivery: Technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=related_link\">",
"      Diagnosis of urinary tract obstruction and hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/57/29592?source=related_link\">",
"      Diagnostic cystourethroscopy for gynecologic conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/43/14010?source=related_link\">",
"      Evaluation of adults with ascites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/39/15994?source=related_link\">",
"      Operative vaginal delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15242?source=related_link\">",
"      Placement and management of indwelling ureteral stents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14730?source=related_link\">",
"      Radical hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33562?source=related_link\">",
"      Stress urinary incontinence in women: Retropubic midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33401?source=related_link\">",
"      Stress urinary incontinence in women: Transobturator midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/40/43655?source=related_link\">",
"      Surgical repair of an iatrogenic ureteral injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=related_link\">",
"      Urinary tract infection associated with urethral catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44792?source=related_link\">",
"      Urogenital tract fistulas in women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_27_7610="Anaphylaxis in pregnant and breastfeeding women";
var content_f7_27_7610=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anaphylaxis in pregnant and breastfeeding women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Michael Schatz, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7610/contributors\">",
"     F Estelle R Simons, MD, FRCPC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Mitchell P Dombrowski, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7610/contributors\">",
"     David L Hepner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/27/7610/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/27/7610/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis is defined clinically as \"a serious allergic reaction that is rapid in onset and may cause death\" [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/1\">",
"     1",
"    </a>",
"    ]. In pregnancy, it can be catastrophic for both mother and fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"     2",
"    </a>",
"    ]. This topic will review issues specific to anaphylaxis in pregnant and breastfeeding women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lifetime prevalence of anaphylaxis in the general population is estimated as 0.05 to 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Data regarding the prevalence among pregnant women is limited. One study estimated the prevalence of anaphylaxis in women near or at the time of delivery in state-licensed hospitals in Texas and reported 2.7 cases of anaphylaxis per 100,000 deliveries (95% CI 1.7-4.2) (ie, 0.002 to 0.004 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observations about anaphylaxis in pregnant and breastfeeding women are largely derived from case reports and small series [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2,6-16\">",
"     2,6-16",
"    </a>",
"    ]. The clinical manifestations of anaphylaxis do not appear to be altered by pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The term \"anaphylactoid\" is no longer recommended for use, and anaphylactic and anaphylactoid reactions do not need to be distinguished with respect to diagnosis and acute treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mother",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis may present with any combination of approximately 40 symptoms and signs (",
"    <a class=\"graphic graphic_table graphicRef66333 \" href=\"UTD.htm?20/36/21068\">",
"     table 1",
"    </a>",
"    ). In pregnant women, it is particularly important to recognize symptoms and signs involving the uterus and fetus (",
"    <a class=\"graphic graphic_figure graphicRef87183 \" href=\"UTD.htm?38/26/39328\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The most common are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cutaneous symptoms, including flushing, itching, urticaria, and angioedema (including periorbital edema and conjunctival swelling).",
"     </li>",
"     <li>",
"      Respiratory symptoms, including nasal discharge, nasal congestion, change in voice quality, sensation of throat closure or choking, cough, wheeze, and dyspnea.",
"     </li>",
"     <li>",
"      Gastrointestinal symptoms, including nausea, vomiting, diarrhea, and crampy abdominal pain.",
"     </li>",
"     <li>",
"      Cardiovascular symptoms, including dizziness, tachycardia, hypotension, and collapse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Anaphylaxis may also present with vaginal itching, uterine cramping, and lower back pain, presumably as a result of degranulation of mast cells in the walls of the vagina and uterus, which are rich in these cells. In vitro studies have demonstrated contraction of uterine smooth muscle of sensitized animals after exposure to specific antigens [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Symptoms related to reproductive organs generally occur along with symptoms in other organ systems, rather than alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Fetus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal IgE does not normally cross the placenta, and (in developed countries where parasites are not endemic) fetal blood usually does not contain significant amounts of allergen-specific IgE [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/10\">",
"     10",
"    </a>",
"    ]. However, maternal anaphylaxis can lead to significant fetal morbidity and mortality if uterine perfusion and maternal oxygenation are compromised. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Outcomes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TRIGGERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any agent that can trigger anaphylaxis in the nonpregnant state can potentially trigger it in a susceptible pregnant woman [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2,6,11,17\">",
"     2,6,11,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following triggers are of particular interest during pregnancy, labor, and delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics administered for prophylaxis against Group B streptococcal (GBS) infection during labor and delivery are the most commonly reported trigger of anaphylaxis in pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/11,12,18-26\">",
"     11,12,18-26",
"    </a>",
"    ]. These medications include penicillin [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/11,22,26\">",
"     11,22,26",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/20,23,24\">",
"     20,23,24",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/21,25\">",
"     21,25",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antibiotic anaphylaxis during pregnancy is typically reported in hospitalized women in association with surgical prophylaxis before scheduled cesarean delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/12\">",
"     12",
"    </a>",
"    ], during prophylaxis of neonatal GBS infection, or during treatment of maternal pyrexia during labor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/11,18-26\">",
"     11,18-26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Anesthetic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications used for neuraxial and general anesthesia have been reported to cause anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Neuromuscular blocking agents, such as suxamethonium, are the most common cause.",
"   </p>",
"   <p>",
"    Local anesthetics used for neuraxial anesthesia can cause vasovagal responses, tachycardia, lightheadedness, metallic taste, and perioral numbness, but these signs and symptoms are more likely the result of accidental intravascular injection, rather than an immune mediated reaction. Anaphylactic reactions to local anesthetics are extremely rare, and true allergic reactions account for less than 1 percent of all drug reactions to local anesthetics. The most common immune mediated reaction to local anesthetics is a delayed hypersensitivity reaction, or contact dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42809?source=see_link&amp;anchor=H4#H4\">",
"     \"Perioperative anaphylaxis: Clinical manifestations, etiology, and diagnosis\", section on 'Etiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/62/34792?source=see_link\">",
"     \"Allergic reactions to local anesthetics\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Oxytocin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis to exogenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/31-39\">",
"     31-39",
"    </a>",
"    ]. Positive immediate (read at 20 minutes) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/35\">",
"     35",
"    </a>",
"    ], delayed (read at five days) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/34\">",
"     34",
"    </a>",
"    ], and negative [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/33\">",
"     33",
"    </a>",
"    ] skin tests to oxytocin have been described in these patients. In some cases, the reactions may have been due to concurrent latex exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/37,38\">",
"     37,38",
"    </a>",
"    ], and in another case, symptoms may have been attributable to chlorbutol, an \"inactive\" ingredient in the oxytocin preparation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Intravenous iron",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iron administration is commonly used to treat anemia secondary to hemorrhage in pregnant and postpartum women. Although hemoglobin levels rise faster with parenteral iron therapy than with oral therapy, administration of parenteral iron is rarely indicated, given the risk of non-IgE-mediated anaphylaxis and the cost. In most women, the anemia resolves sufficiently rapidly with oral iron treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25578?source=see_link\">",
"     \"Treatment of anemia due to iron deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laminaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laminaria are used to dilate the cervix, primarily prior to pregnancy termination. There are four case reports of anaphylaxis associated with laminaria placement [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Natural rubber latex",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensitization to latex appears to occur more frequently in women than in men, and obstetrical and gynecological surgical procedures are a common setting for latex anaphylaxis in women in their reproductive years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9785?source=see_link\">",
"     \"Latex allergy: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Breastfeeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breastfeeding has been implicated as a trigger of anaphylaxis in several case reports, sometimes in association with the administration of nonsteroidal antiinflammatory drugs (NSAIDs), which are also potential anaphylaxis triggers [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/45-49\">",
"     45-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one patient, anaphylaxis occurred after breastfeeding following two deliveries [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/45\">",
"       45",
"      </a>",
"      ]. After her first delivery, anaphylaxis occurred 30 minutes after the first breastfeeding. The symptoms resolved, but recurred within minutes of the second feeding four hours later, and again with every feeding for three days. Discontinuation of NSAIDs and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen (paracetamol)",
"      </a>",
"      seemed to improve her symptoms, but she remained symptomatic until one month postpartum, when breastfeeding and manual milk expression were halted. Five years later, after her second delivery, anaphylaxis with breastfeeding recurred 48 hours postpartum; suppression of lactation with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/40/8840?source=see_link\">",
"       bromocriptine",
"      </a>",
"      led to complete resolution of symptoms.",
"     </li>",
"     <li>",
"      In another patient, anaphylaxis began on the third postpartum day and resolved on day four, despite continuation of breastfeeding [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a third patient, anaphylaxis with breastfeeding occurred on the third postpartum day in four consecutive pregnancies, although the patient could breastfeed uneventfully on the days before and after the third day [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/47\">",
"       47",
"      </a>",
"      ]. Prophylaxis with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      30 mg twice daily and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36390?source=see_link\">",
"       cetirizine",
"      </a>",
"      10 mg daily were administered just after the fourth delivery; symptoms occurred again, but were milder. This patient had also received NSAIDs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mechanism underlying breastfeeding anaphylaxis is unclear. Skin testing with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    and breast milk were performed in some of the cases described above, with negative results [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/45,47\">",
"     45,47",
"    </a>",
"    ]. Changing levels of progesterone",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    prolactin were suggested as possible predisposing factors [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;As in nonpregnant individuals, venom from stinging Hymenoptera insects (eg, honeybees, yellow jackets, hornets, wasps, or ants, including fire ants) and ingestion of foods (eg, shellfish, peanuts, or tree nuts) can cause anaphylaxis during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/50-53\">",
"     50-53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/1/12313?source=see_link\">",
"     \"Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=see_link\">",
"     \"Seafood allergies: Fish and shellfish\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients have no obvious trigger, and are considered to have idiopathic anaphylaxis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34071?source=see_link\">",
"     \"Idiopathic anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of anaphylaxis during pregnancy is similar to the diagnosis in nonpregnant patients and is based on a meticulous history and physical examination. Clinical criteria for diagnosing anaphylaxis have been defined and can be applied to pregnant women (",
"    <a class=\"graphic graphic_table graphicRef72225 \" href=\"UTD.htm?22/43/23228\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some, but not all patients, the clinical diagnosis of anaphylaxis can be confirmed by an elevated serum total tryptase level measured in a blood sample drawn shortly after the onset of symptoms. Blood for serum tryptase is optimally obtained 15 minutes to 3 hours after symptom onset. Any elevation in serum tryptase provides evidence of mast cell activation, and thus supports a diagnosis of anaphylaxis, although elevated tryptase levels have also been reported in amniotic fluid and embolism [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/54\">",
"     54",
"    </a>",
"    ]. However, in some patients with anaphylaxis, (eg, those with food-triggered anaphylaxis or those who are normotensive), elevations in tryptase generally do not occur. A normal tryptase level cannot be used to refute the diagnosis of anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2,55\">",
"     2,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum tryptase assays are widely available in clinical laboratories, although results can seldom be obtained on an urgent basis. The interpretation of tryptase levels, and other tests that can support the diagnosis of anaphylaxis, are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40809?source=see_link\">",
"     \"Laboratory tests to support the clinical diagnosis of anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of anaphylaxis during pregnancy includes all of the disorders that can mimic aspects of anaphylaxis in nonpregnant individuals (",
"    <a class=\"graphic graphic_table graphicRef65677 \" href=\"UTD.htm?40/61/41948\">",
"     table 3",
"    </a>",
"    ) as well as some disorders unique to pregnancy, labor, and delivery (",
"    <a class=\"graphic graphic_table graphicRef78410 \" href=\"UTD.htm?14/26/14763\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"     2",
"    </a>",
"    ]. The differential diagnosis of anaphylaxis is reviewed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38888?source=see_link\">",
"     \"Differential diagnosis of anaphylaxis in children and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Other causes of laryngeal edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laryngeal obstruction, a frequent and potentially life-threatening symptom of anaphylaxis, must be differentiated from the laryngeal edema associated with preeclampsia, as well as that caused by laryngopathia gravidarum.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preeclampsia &mdash; The presence of hypertension and proteinuria in preeclampsia are helpful in making the correct diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/20/27978?source=see_link\">",
"       \"Preeclampsia: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Laryngopathia gravidarum &mdash; Laryngopathia gravidarum refers to the changes in laryngeal function observed in pregnancy. In the acute type, symptoms of dyspnea, hoarseness, sore throat, and painful swallowing occur just prior to delivery, and laryngeal examination reveals edema. In the chronic form, the symptoms are similar, but begin earlier in pregnancy and persist [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/56\">",
"       56",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/52/3914?source=see_link&amp;anchor=H20#H20\">",
"       \"Recognition and management of allergic disease during pregnancy\", section on 'Urticaria and angioedema'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hereditary angioedema &mdash; Laryngeal obstruction also occurs in hereditary angioedema (HAE), but laryngeal stridor usually develops over hours rather than minutes. In addition, patients often have a history of recurrent unexplained abdominal pain or episodes of cutaneous swelling. There may also be a family history of HAE. Urticaria (hives) and itching are not present in HAE, but are common features of anaphylaxis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19272?source=see_link\">",
"       \"Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33864?source=see_link\">",
"       \"Hereditary angioedema: Pathogenesis and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other causes of hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypotension may be a prominent feature of severe anaphylaxis and must be differentiated from other causes of hypotension during pregnancy, such as spinal block, local anesthesia, or hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"     2",
"    </a>",
"    ]. The sudden onset of pruritus, urticaria, angioedema, stridor, or wheezing, in addition to hypotension, strongly supports a diagnosis of anaphylaxis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Amniotic fluid embolism syndrome",
"      </strong>",
"      &mdash; Amniotic fluid embolism syndrome is an important cause of acute cardiovascular collapse during pregnancy and can be difficult to distinguish clinically from anaphylaxis. This entity is reviewed briefly here and described in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15016?source=see_link\">",
"       \"Amniotic fluid embolism syndrome\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Suggested criteria for amniotic fluid embolism syndrome include one or more of the clinical findings of sudden onset cardiovascular collapse, respiratory distress, or disseminated intravascular coagulation during pregnancy, and absence of other medical explanations for the clinical course.",
"      <br/>",
"      <br/>",
"      Bronchospasm is characteristic of anaphylaxis, rather than amniotic fluid embolism [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/57\">",
"       57",
"      </a>",
"      ], while large volume blood loss should raise suspicion for amniotic fluid embolism. Coagulopathy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      disseminated intravascular coagulation are more often associated with amniotic fluid embolism, although activation of both the contact system and the coagulation system can also occur in anaphylaxis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/55,58\">",
"       55,58",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Amniotic fluid embolism has been termed anaphylactoid syndrome of pregnancy by some authors [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/59\">",
"       59",
"      </a>",
"      ]. The proposed mechanism is a non-IgE-mediated reaction to fetal antigens leading to mast cell degranulation and release of histamine and tryptase, an elevated beta-tryptase level was reported in one fatal case [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/54\">",
"       54",
"      </a>",
"      ]. Complement activation has also been suggested as a possible mechanism [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/60\">",
"       60",
"      </a>",
"      ]. Blood tests for Sialyl Tn may also be helpful in diagnosis, as this is a possible marker for severe amniotic fluid embolism, and appears to be predictive for life-threatening or fatal episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/57\">",
"       57",
"      </a>",
"      ]. Serum tryptase levels may be increased in amniotic fluid.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;When anaphylaxis occurs in pregnancy, there appears to be a significant risk of",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    neurologic damage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    death even when the maternal outcome is favorable [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fetal oxygen delivery is a function of the Fick principle: each volume of blood passing through the uterus and placenta releases oxygen as a function of the magnitude of the pO2 difference between the fetal and maternal circulation. The uterine artery functions as a near-maximally dilated system to maximize oxygen delivery to the fetus. However, the fetus can compensate for decreased blood flow by increasing oxygen uptake, redistributing circulation to vital organs (brain, heart, adrenal glands, placenta), decreasing gross body movements, and increasing tissue oxygen extraction. The exact level and duration of fetal hypoxia that exceed these compensatory mechanisms are affected by fetal reserve and gestational age [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maternal anaphylaxis affects the fetus in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal hypoxemia directly reduces the oxygen supply for the fetus.",
"     </li>",
"     <li>",
"      Maternal hypotension reduces uterine perfusion, which in turn, reduces oxygen supply to the fetus.",
"     </li>",
"     <li>",
"      Maternal alkalosis decreases uterine blood flow by vasoconstriction and increases the affinity of maternal hemoglobin for oxygen, which reduce the oxygen supply for the fetus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a result, anaphylaxis may lead to significant fetal morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A comprehensive literature review of anaphylaxis during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/11\">",
"     11",
"    </a>",
"    ] identified 18 cases of anaphylaxis occurring prior to delivery in which the fetal outcomes were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/13-15,19-29,43,53,63\">",
"     13-15,19-29,43,53,63",
"    </a>",
"    ]. We identified an additional 10 cases in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/12,16,18,40,50-52,64-66\">",
"     12,16,18,40,50-52,64-66",
"    </a>",
"    ]. Of these 28 cases published through 2008, 16 occurred during labor or just before cesarean delivery, and 6 cases occurred at less than 32 weeks of gestation. The major findings of this review were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There were no maternal deaths in the 28 cases.",
"     </li>",
"     <li>",
"      There were four perinatal deaths [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/12,26,51,66\">",
"       12,26,51,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Neurological abnormalities, some of which were severe, were reported in nine infants. Three of these infants were delivered to women who had anaphylaxis at less than 32 weeks gestation, and four were delivered to women who had anaphylaxis during labor and delivery.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       Epinephrine",
"      </a>",
"      was administered before delivery in only 12 of 28 cases. Among these 12 mothers, 6 delivered healthy infants and 4 delivered infants with neurological abnormalities. Two infants died.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Maternal",
"    </span>",
"    &nbsp;&mdash;&nbsp;With a few modifications, the medical management of anaphylaxis during pregnancy is the same as in nonpregnant patients. A rapid overview of anaphylaxis treatment is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef87553 \" href=\"UTD.htm?9/47/9981\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"     2",
"    </a>",
"    ]. A more detailed presentation of the diagnosis and treatment of anaphylaxis is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H18#H18\">",
"     \"Anaphylaxis: Rapid recognition and treatment\", section on 'Immediate management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The modifications that are important in pregnant women include positioning the patient on her left side to prevent compression of the aortocaval vessels by the gravid uterus, maintaining a minimum maternal systolic blood pressure of 90 mmHg, and fetal monitoring (",
"    <a class=\"graphic graphic_figure graphicRef87184 \" href=\"UTD.htm?15/20/15690\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Intramuscular epinephrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     Epinephrine",
"    </a>",
"    is considered the drug of choice in the treatment of anaphylaxis, in both nonpregnant and pregnant patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/67\">",
"     67",
"    </a>",
"    ]. No alternative drug more completely treats the physiologic manifestations of anaphylaxis.",
"   </p>",
"   <p>",
"    Current recommendations call for prompt INTRAMUSCULAR injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    . The correct dosing and administration of epinephrine are discussed separately (",
"    <a class=\"graphic graphic_table graphicRef58346 \" href=\"UTD.htm?16/26/16813\">",
"     table 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H24#H24\">",
"     \"Anaphylaxis: Rapid recognition and treatment\", section on 'Epinephrine'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H26#H26\">",
"     \"Anaphylaxis: Rapid recognition and treatment\", section on 'Dosing and administration'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    injection, patients should not suddenly sit or stand up, as this can lead to cardiac arrest due to the empty inferior vena",
"    <span class=\"nowrap\">",
"     cava/empty",
"    </span>",
"    ventricle syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Concerns regarding the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    during pregnancy have been raised because of its potential to reduce uterine blood flow through alpha adrenergic-mediated blood vessel vasoconstriction in the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/11\">",
"     11",
"    </a>",
"    ]. Inguinal hernia is the only malformation that has been specifically associated with epinephrine use in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/69\">",
"     69",
"    </a>",
"    ]. Thus, evidence of significant fetal harm in humans is limited.",
"   </p>",
"   <p>",
"    Infant deaths and neurological abnormalities have been associated with maternal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    treatment of anaphylaxis during pregnancy. However, these adverse outcomes are likely due to fetal hypoxia related to severe anaphylaxis itself, rather than to epinephrine treatment. Furthermore, healthy infants have been delivered to a number of pregnant women who were treated with epinephrine for anaphylaxis, including one patient who received a continuous intravenous epinephrine infusion for 3.5 hours to treat refractory anaphylaxis during labor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/23\">",
"     23",
"    </a>",
"    ]. Moreover, perinatal deaths or infant neurological abnormalities have occurred in women with anaphylaxis who were NOT treated with epinephrine, as described previously.",
"   </p>",
"   <p>",
"    Controlled trials of the advantages and disadvantages of various vasopressors are underway. A few case reports have suggested ephedrine by the intravenous route as an alternative to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    during anaphylaxis in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/11\">",
"     11",
"    </a>",
"    ]. Ephedrine is a non-catechol sympathomimetic with alpha- and beta-adrenergic effects. However, it is a less potent vasoconstrictor and bronchodilator than epinephrine [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/70\">",
"     70",
"    </a>",
"    ], and intravenous formulations of ephedrine are not universally available. In prospective clinical trials conducted in women undergoing elective cesarean section, in comparative studies versus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    , ephedrine was significantly more likely to decrease uterine and placental blood flow and to increase fetal distress and acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/71-73\">",
"     71-73",
"    </a>",
"    ]. Thus, epinephrine remains the recommended agent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Supplemental oxygen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supplemental oxygen, six to eight liters by face mask, up to 100 percent, should be administered (",
"    <a class=\"graphic graphic_table graphicRef87553 \" href=\"UTD.htm?9/47/9981\">",
"     table 5",
"    </a>",
"    ). Oxygen is important because",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    , like other alpha-1 adrenergic vasoconstrictors, can potentially worsen the",
"    <span class=\"nowrap\">",
"     ventilation/perfusion",
"    </span>",
"    ratio [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Fluid resuscitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate intravascular volume repletion and oxygenation are particularly important in the management of anaphylaxis in pregnant women in order to prevent both maternal and fetal complications (",
"    <a class=\"graphic graphic_table graphicRef87553 \" href=\"UTD.htm?9/47/9981\">",
"     table 5",
"    </a>",
"    ): (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient should be placed on her left side to prevent added positional hypotension resulting from compression of the aortocaval vessels by the gravid uterus.",
"     </li>",
"     <li>",
"      Impending or existing hypotension must be promptly reversed with large volumes of intravenous fluids, preferably normal (isotonic) saline. In nonpregnant adults with anaphylaxis, one to two liters of normal saline may be needed in the first 30 minutes of treatment. The rate of infusion should be titrated against blood pressure, cardiac rate and function ascertained by continuous noninvasive monitoring, and urine output. Glucose containing solutions should be avoided, as these fluids can result in a large glucose bolus, which reduces umbilical cord pH and can cause neonatal hypoglycemia.",
"     </li>",
"     <li>",
"      A minimum maternal systolic blood pressure of 90 mmHg should be maintained to ensure adequate placental perfusion and fetal oxygenation, since uterine blood flow is not autoregulated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Other measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adjunctive treatments for anaphylaxis include H1-antihistamines, inhaled bronchodilators, and glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      H1-antihistamines &mdash; H1-antihistamines treat itching and hives, but these agents do NOT prevent or relieve upper or lower airway obstruction, and do NOT prevent or relieve shock. The safety of H1-antihistamines was affirmed in a meta-analysis that examined the association between antihistamine use and major congenital malformations [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/76\">",
"       76",
"      </a>",
"      ]. This review of 24 controlled studies, including over 200,000 first trimester exposures, found that H1-antihistamines actually had a protective effect on risk of malformations (OR 0.76, 95% CI 0.60-0.94).",
"      <br/>",
"      <br/>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"       Diphenhydramine",
"      </a>",
"      (50 mg intravenously) can be given to decrease hives and itching if a parenteral agent is desired [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/77\">",
"       77",
"      </a>",
"      ]. No second-generation H1-antihistamine is available in a parenteral formulation.",
"      <br/>",
"      <br/>",
"      Among oral agents, the second-generation H1-antihistamines",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36390?source=see_link\">",
"       cetirizine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/39/7799?source=see_link\">",
"       loratadine",
"      </a>",
"      are preferred over other oral H1-antihistamines for use in pregnancy because of reassuring pregnancy safety data and because second generation agents are significantly less likely to impair CNS function and cause sedation or other adverse effects [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/77\">",
"       77",
"      </a>",
"      ]. Loratadine (and other nonimpairing, nonsedating H1-antihistamines) are minimally excreted in breast milk [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/78\">",
"       78",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bronchodilators &mdash; A selective beta-2 adrenergic agonist, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"       albuterol",
"      </a>",
"      , may be administered by nebulizer and face mask if wheezing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coughing are prominent symptoms.",
"     </li>",
"     <li>",
"      Glucocorticoids &mdash; A glucocorticoid (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intravenously every eight hours for two or three doses) can be administered to patients with severe anaphylaxis to reduce the risk of protracted or biphasic anaphylaxis, although efficacy is unproven and doses are extrapolated from asthma treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/79\">",
"       79",
"      </a>",
"      ]. Biphasic anaphylaxis, (ie, the recurrence of symptoms after initial symptoms have resolved despite no further exposure to the trigger), may occur 1 to 72 hours after the initial anaphylaxis symptoms have resolved [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Fetal monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to continuous electronic monitoring of maternal heart rate, blood pressure, ECG, and oxygenation, we suggest continuous electronic fetal heart monitoring of viable fetuses (greater than 23 to 24 weeks of gestation) in pregnancies complicated by anaphylaxis. Fetal heart rate monitoring can be a more sensitive assessment of maternal cardiorespiratory status than maternal vital signs, as maternal hemodynamic stability does not guarantee that placental perfusion and fetal oxygenation are optimal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/7/23674?source=see_link\">",
"     \"Intrapartum fetal heart rate assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is preferable to manage nonreassuring fetal heart rate patterns by correcting maternal hypotension",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypoxemia with aggressive maternal medical management of the anaphylaxis. However, emergency cesarean delivery should be performed for a viable fetus with a persistently nonreassuring tracing (absent baseline variability plus recurrent late decelerations, recurrent variable decelerations, or bradycardia) despite aggressive maternal medical management.",
"   </p>",
"   <p>",
"    The potential benefits of an emergent delivery in cases of refractory anaphylaxis must be balanced against the surgical risks to the gravida with hypotension and hypoxia. In addition, the potential benefits should be balanced against neonatal morbidity and mortality secondary to prematurity, especially if the gestational age is less than 32 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Refractory anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with anaphylaxis that is not responding completely to initial management should be admitted to an intensive care unit without delay. There are no published prospective studies on the optimal management of refractory anaphylactic shock.",
"   </p>",
"   <p>",
"    Anaphylactic shock displays features of both distributive (vasodilatory) and hypovolemic shock. The management of severe forms of these types of shock is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10346?source=see_link\">",
"     \"Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=see_link\">",
"     \"Hypovolemic shock in children: Initial evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\", section on 'Vasopressors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13639?source=see_link\">",
"     \"Treatment of severe hypovolemia or hypovolemic shock in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strategies for the prevention of anaphylaxis during pregnancy primarily involve identification and avoidance of the specific triggers to which the patient is sensitive, including foods, medications, insect stings, and latex. This begins with a thorough medical history. Patients with histories of reactions to latex or agents that may be required during pregnancy (eg, beta-lactam antibiotics, local anesthetics, or neuromuscular blocking drugs) should ideally be referred to an allergy specialist for evaluation PRIOR to pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Patients with drug allergies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women should be questioned carefully about past adverse drug reactions. Specific questions that help uncover important information about past reactions are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/62/24554?source=see_link&amp;anchor=H18#H18\">",
"     \"An approach to the patient with drug allergy\", section on 'Clinical history'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with a history of adverse reactions to penicillins who need these drugs during labor for prophylaxis against group B streptococcal infection can be managed in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If this history is obtained in advance, referral to an allergy specialist may be arranged. Skin testing is generally avoided during pregnancy because of the small, but definite risk that the procedure can induce a systemic allergic reaction. However, in exceptional circumstances, skin testing and even desensitization have been successfully performed in pregnant women [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/82-86\">",
"       82-86",
"      </a>",
"      ]. One scenario in which this is indicated is the need to administer penicillin to a penicillin-allergic pregnant woman to eradicate syphilis and prevent congenital syphilis in the infant. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/61/4057?source=see_link&amp;anchor=H23#H23\">",
"       \"Syphilis in pregnancy\", section on 'Penicillin allergy'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Another situation in which possible penicillin allergy in a pregnant woman requires careful consideration is the need to treat following a positive culture for group B streptococcus. This is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link&amp;anchor=H13#H13\">",
"       \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\", section on 'Patients with penicillin allergy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If skin testing is considered, it may be prudent to perform it as late as possible in the pregnancy, in case an allergic reaction were to develop and emergency delivery became necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=see_link&amp;anchor=H1968768#H1968768\">",
"       \"Allergy to penicillins\", section on 'Penicillin skin testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If referral to an allergist or skin testing is not possible, an antibiotic that does not cross-react with the suspect culprit antibiotic should be given. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link&amp;anchor=H13#H13\">",
"       \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\", section on 'Patients with penicillin allergy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Patients with latex allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women should be questioned about possible latex allergy and about past reactions to common latex-containing objects. These objects include latex gloves, balloons, condoms, pacifiers, teethers, bottle nipples, and adhesives for hair extensions. Objects commonly used in medical procedures include latex gloves, balloon tipped catheters (eg, used during",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema examination, pulmonary artery catheterization), and dental cofferdams. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9785?source=see_link\">",
"     \"Latex allergy: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of patients with latex allergy primarily involves the provision of care in a latex-free environment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40070?source=see_link\">",
"     \"Latex allergy: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Patients with insect sting allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with possible systemic allergic reactions to insect stings (eg, honeybees, yellow jackets, hornets, and wasps ) should be evaluated by an allergy specialist to see if they are candidates for immunotherapy with standardized stinging insect venom (VIT). VIT involves a series of injections administered over a period of three to five years. It significantly reduces the patient's risk of anaphylaxis or other systemic reactions to stinging insect venom. It provides protection for years after injections are discontinued.",
"   </p>",
"   <p>",
"    VIT is not typically initiated during pregnancy; however, if a woman becomes pregnant while receiving VIT maintenance doses, it may be safely continued without dose escalation. Venom immunotherapy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=see_link&amp;anchor=H13#H13\">",
"     \"Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action\", section on 'Pregnant women'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Emergency preparedness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women who are at risk of anaphylaxis in the community setting should be counseled to take the following precautions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Carry one or more",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      autoinjectors at all times. Patients should be trained in how to use an epinephrine autoinjector correctly and when to use it. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=see_link\">",
"       \"Prescribing epinephrine for anaphylaxis self-treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"       \"Patient information: Use of an epinephrine autoinjector (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Carry an anaphylaxis emergency action plan at all times. This document should be developed with input from the patient and should describe the importance of prompt intramuscular injection of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      , and calling 911 or emergency medical services. (",
"      <a class=\"graphic graphic_form graphicRef60439 \" href=\"UTD.htm?2/42/2722\">",
"       form 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Obtain a medical identification bracelet or necklace listing their known allergies and any relevant co-morbidities (eg, asthma, cardiovascular conditions, mastocytosis) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/27/7610/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Written communication with the patients' obstetrician",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      other clinicians is important.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, referral to an allergy specialist should be arranged. The immediate and long-term care of patients with anaphylaxis is presented in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H37#H37\">",
"     \"Anaphylaxis: Rapid recognition and treatment\", section on 'Care upon resolution'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9401?source=see_link\">",
"     \"Anaphylaxis: Confirming the diagnosis and determining the trigger(s)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anaphylaxis is not common during pregnancy. However, it is important to recognize it rapidly, and treat it effectively, as the maternal hypoxia and hypotension that can result may be catastrophic to both mother and fetus. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anaphylaxis may present with various combinations of up to 40 potential symptoms and signs (",
"      <a class=\"graphic graphic_table graphicRef66333 \" href=\"UTD.htm?20/36/21068\">",
"       table 1",
"      </a>",
"      ). Common features include pruritus (sometimes involving the vagina and vulva), urticaria, angioedema, bronchospasm, tachycardia, and hypotension. In pregnant women, anaphylaxis may also induce lower back pain, uterine cramping, fetal distress, and preterm labor (",
"      <a class=\"graphic graphic_figure graphicRef87183 \" href=\"UTD.htm?38/26/39328\">",
"       figure 1",
"      </a>",
"      ). The fetus may demonstrate varying degrees of fetal distress. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Triggers of anaphylaxis in pregnancy include those that typically occur in the community setting (eg, foods, medications, or insect stings), and triggers that are specifically encountered in medical settings, including labor and delivery, such as latex, antibiotics, and neuromuscular blocking drugs. Breastfeeding may also trigger anaphylaxis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Triggers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of anaphylaxis in pregnancy is based on the clinical history and on physical signs (",
"      <a class=\"graphic graphic_table graphicRef72225 \" href=\"UTD.htm?22/43/23228\">",
"       table 2",
"      </a>",
"      ). It is sometimes confirmed by laboratory tests, such as an elevated serum total tryptase level. A tryptase level that is within normal limits cannot be used to refute the diagnosis. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Maternal hypoxemia and hypotension in anaphylaxis are associated with a high risk of hypoxic-ischemic encephalopathy or death in the fetus, even when the material outcome is positive. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medical management of anaphylaxis in a pregnant woman is similar to management in the nonpregnant patient and involves prompt intramuscular injection of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      , adequate supplemental oxygen, and intravenous fluid resuscitation (",
"      <a class=\"graphic graphic_table graphicRef87553 \" href=\"UTD.htm?9/47/9981\">",
"       table 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef87184 \" href=\"UTD.htm?15/20/15690\">",
"       figure 2",
"      </a>",
"      ). The fetal heart rate should be monitored if the fetus has reached a viable gestational age. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prevention of anaphylaxis during pregnancy begins with a careful history to uncover any past allergic reactions that may provide clues about potential allergies to foods, medications, insect stings, latex, or other allergens. Women with past anaphylaxis should prepare for a potential recurrence (ie,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      autoinjector, anaphylaxis emergency action plan, and medical identification). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/1\">",
"      Sampson HA, Mu&ntilde;oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/2\">",
"      Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/3\">",
"      Clark S, Camargo CA Jr. Epidemiology of anaphylaxis. Immunol Allergy Clin North Am 2007; 27:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/4\">",
"      Decker WW, Campbell RL, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/5\">",
"      Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006; 97:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/6\">",
"      Mulla ZD, Ebrahim MS, Gonzalez JL. Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database. Ann Allergy Asthma Immunol 2010; 104:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/7\">",
"      Simons FE. Anaphylaxis. J Allergy Clin Immunol 2010; 125:S161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/8\">",
"      KATSH S, MARSHALL JM. Electrical and mechanical responses of uterine smooth muscle during anaphylaxis in vitro. Am J Physiol 1959; 196:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/9\">",
"      Chand N, Eyre P. The Schultz-Dale reaction: a review. Agents Actions 1978; 8:171.",
"     </a>",
"    </li>",
"    <li>",
"     Smith PH, Ownby DR. Clinical significance of immunoglobulin E. In: Middleton's allergy principles and practice, 7th ed, Adkinson NF, Bochner BS, Busse WW, et al (Eds), Mosby, Philadelphia 2009. p.845.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/11\">",
"      Chaudhuri K, Gonzales J, Jesurun CA, et al. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth 2008; 17:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/12\">",
"      Sengupta A, Kohli JK. Antibiotic prophylaxis in cesarean section causing anaphylaxis and intrauterine fetal death. J Obstet Gynaecol Res 2008; 34:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/13\">",
"      Luciano R, Zuppa AA, Maragliano G, et al. Fetal encephalopathy after maternal anaphylaxis. Case report. Biol Neonate 1997; 71:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/14\">",
"      Entman SS, Moise KJ. Anaphylaxis in pregnancy. South Med J 1984; 77:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/15\">",
"      Porter BJ, Acharya U, Ormerod AD, Herriot R. Latex/chlorhexidine-induced anaphylaxis in pregnancy. Allergy 1998; 53:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/16\">",
"      Suri S, Salfield S, Baxter P. Congenital paraplegia following maternal hypotension. Dev Med Child Neurol 1999; 41:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/17\">",
"      Romero R, Kusanovic JP, Mu&ntilde;oz H, et al. Allergy-induced preterm labor after the ingestion of shellfish. J Matern Fetal Neonatal Med 2010; 23:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/18\">",
"      Khan R, Anastasakis E, Kadir RA. Anaphylactic reaction to ceftriaxone in labour. An emerging complication. J Obstet Gynaecol 2008; 28:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/19\">",
"      Gallagher JS. Anaphylaxis in pregnancy. Obstet Gynecol 1988; 71:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/20\">",
"      Heim K, Alge A, Marth C. Anaphylactic reaction to ampicillin and severe complication in the fetus. Lancet 1991; 337:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/21\">",
"      Konno R, Nagase S. Anaphylactic reaction to cefazolin in pregnancy. J Obstet Gynaecol (Tokyo 1995) 1995; 21:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/22\">",
"      Dunn AB, Blomquist J, Khouzami V. Anaphylaxis in labor secondary to prophylaxis against group B Streptococcus. A case report. J Reprod Med 1999; 44:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/23\">",
"      Gei AF, Pacheco LD, Vanhook JW, Hankins GD. The use of a continuous infusion of epinephrine for anaphylactic shock during labor. Obstet Gynecol 2003; 102:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/24\">",
"      Berardi A, Rossi K, Cavalleri F, et al. Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis. J Perinat Med 2004; 32:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/25\">",
"      Jao MS, Cheng PJ, Shaw SW, Soong YK. Anaphylaxis to cefazolin during labor secondary to prophylaxis for group B Streptococcus: a case report. J Reprod Med 2006; 51:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/26\">",
"      Sheikh J. Intrapartum anaphylaxis to penicillin in a woman with rheumatoid arthritis who had no prior penicillin allergy. Ann Allergy Asthma Immunol 2007; 99:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/27\">",
"      Sitarz L. Anaphylactic shock following injection of suxamethonium. Anaesth Resusc Intensive Ther 1974; 2:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/28\">",
"      Edmondson WC, Skilton RW. Anaphylaxis in pregnancy--the right treatment? Anaesthesia 1994; 49:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/29\">",
"      Baraka A, Sfeir S. Anaphylactic cardiac arrest in a parturient. Response of the newborn. JAMA 1980; 243:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/30\">",
"      Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003; 97:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/31\">",
"      Lin MC, Hsieh TK, Liu CA, et al. Anaphylactoid shock induced by oxytocin administration--a case report. Acta Anaesthesiol Taiwan 2007; 45:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/32\">",
"      Shimo T, Nishiike S, Masuoka M, et al. [Intraoperative anaphylactic shock induced by methylergometrine and oxytocin]. Masui 2006; 55:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/33\">",
"      Slater RM, Bowles BJ, Pumphrey RS. Anaphylactoid reaction to oxytocin in pregnancy. Anaesthesia 1985; 40:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/34\">",
"      Emmott RS. Recurrent anaphylactoid reaction during caesarean section. Anaesthesia 1990; 45:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/35\">",
"      Pant D, Vohra VK, Pandey SS, Sood J. Pulseless electrical activity during caesarean delivery under spinal anaesthesia: a case report of severe anaphylactic reaction to Syntocinon. Int J Obstet Anesth 2009; 18:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/36\">",
"      Cabestrero D, P&eacute;rez-Paredes C, Fern&aacute;ndez-Cid R, Arribas MA. Bronchospasm and laryngeal stridor as an adverse effect of oxytocin treatment. Crit Care 2003; 7:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/37\">",
"      Morriss WW, Lavies NG, Anderson SK, Southgate HJ. Acute respiratory distress during caesarean section under spinal anaesthesia. A probable case of anaphylactoid reaction to Syntocinon. Anaesthesia 1994; 49:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/38\">",
"      Ogata J, Minami K. Synthetic oxytocin and latex allergy. Br J Anaesth 2007; 98:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/39\">",
"      Maycock EJ, Russell WC. Anaphylactoid reaction to Syntocinon. Anaesth Intensive Care 1993; 21:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/40\">",
"      Cuciti C, Mayer DC, Arnette R, Spielman FJ. Anaphylactoid reaction to intravenous sodium ferric gluconate complex during pregnancy. Int J Obstet Anesth 2005; 14:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/41\">",
"      Cole DS, Bruck LR. Anaphylaxis after laminaria insertion. Obstet Gynecol 2000; 95:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/42\">",
"      Chanda M, Mackenzie P, Day JH. Hypersensitivity reactions following laminaria placement. Contraception 2000; 62:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/43\">",
"      Eckhout GV Jr, Ayad S. Anaphylaxis due to airborne exposure to latex in a primigravida. Anesthesiology 2001; 95:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/44\">",
"      Draisci G, Nucera E, Pollastrini E, et al. Anaphylactic reactions during cesarean section. Int J Obstet Anesth 2007; 16:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/45\">",
"      Mullins RJ, Russell A, McGrath GJ, et al. Breastfeeding anaphylaxis. Lancet 1991; 338:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/46\">",
"      MacDonell JW, Ito S. Breastfeeding anaphylaxis case study. J Hum Lact 1998; 14:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/47\">",
"      Shank JJ, Olney SC, Lin FL, McNamara MF. Recurrent postpartum anaphylaxis with breast-feeding. Obstet Gynecol 2009; 114:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/48\">",
"      Villalta D, Martelli P. A case of breastfeeding anaphylaxis. Eur Ann Allergy Clin Immunol 2007; 39:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/49\">",
"      McKinney KK, Scranton SE. A case report of breastfeeding anaphylaxis: successful prophylaxis with oral antihistamines. Allergy 2011; 66:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/50\">",
"      Habek D, Cerkez-Habek J, Jalsovec D. Anaphylactic shock in response to wasp sting in pregnancy. Zentralbl Gynakol 2000; 122:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/51\">",
"      Rizk DE, Mensah-Brown E, Lukic M. Placental abruption and intrauterine death following an ant sting. Int J Gynaecol Obstet 1998; 63:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/52\">",
"      Klein VR, Harris AP, Abraham RA, Niebyl JR. Fetal distress during a maternal systemic allergic reaction. Obstet Gynecol 1984; 64:15S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/53\">",
"      Erasmus C, Blackwood W, Wilson J. Infantile multicystic encephalomalacia after maternal bee sting anaphylaxis during pregnancy. Arch Dis Child 1982; 57:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/54\">",
"      Farrar SC, Gherman RB. Serum tryptase analysis in a woman with amniotic fluid embolism. A case report. J Reprod Med 2001; 46:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/55\">",
"      Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007; 120:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/56\">",
"      Bhatia PL, Singh MS, Jha BK. Laryngopathia gravidarum. Ear Nose Throat J 1981; 60:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/57\">",
"      Harboe T, Benson MD, Oi H, et al. Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis. Acta Anaesthesiol Scand 2006; 50:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/58\">",
"      Kishimoto TK, Viswanathan K, Ganguly T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008; 358:2457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/59\">",
"      Clark SL, Hankins GD, Dudley DA, et al. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995; 172:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/60\">",
"      Benson MD, Kobayashi H, Silver RK, et al. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 2001; 97:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/61\">",
"      Cousins L. Fetal oxygenation, assessment of fetal well-being, and obstetric management of the pregnant patient with asthma. J Allergy Clin Immunol 1999; 103:S343.",
"     </a>",
"    </li>",
"    <li>",
"     Cousins L, Catanzarite VA. Fetal oxygenation, acid-base balance, and assessment of well-being in the pregnancy complicated by asthma or anaphylaxis. In: Asthma and immunological diseases in pregnancy and early infancy, Schatz M, Zeiger RS, Claman HN (Eds), Marcel Dekker, New York 1998. p.27.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/63\">",
"      Powell JA, Maycock EJ. Anaphylactoid reaction to ranitidine in an obstetric patient. Anaesth Intensive Care 1993; 21:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/64\">",
"      Greer IA, Fellows K. Anaphalactoid reaction to ranitidine in labour. Br J Clin Pract 1990; 44:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/65\">",
"      Barry JE, Madan R, Hewitt PB. Anaphylactoid reaction to ranitidine in an obstetric patient. Anaesthesia 1992; 47:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/66\">",
"      Jensen-Jarolim E, Reider N, Fritsch R, Breiteneder H. Fatal outcome of anaphylaxis to camomile-containing enema during labor: a case study. J Allergy Clin Immunol 1998; 102:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/67\">",
"      Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy 2009; 64:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/68\">",
"      Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112:451.",
"     </a>",
"    </li>",
"    <li>",
"     www.reprotox.org (Accessed on October 19, 2009).",
"    </li>",
"    <li>",
"     Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Goodman and Gilman's the pharmacological basis of therapeutics, 11th ed, McGraw-Hill Companies, 2006. p.237.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/71\">",
"      Ngan Kee WD, Khaw KS, Lau TK, et al. Randomised double-blinded comparison of phenylephrine vs ephedrine for maintaining blood pressure during spinal anaesthesia for non-elective Caesarean section*. Anaesthesia 2008; 63:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/72\">",
"      Ngan Kee WD, Khaw KS, Tan PE, et al. Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 2009; 111:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/73\">",
"      Riley ET. Editorial I: Spinal anaesthesia for Caesarean delivery: keep the pressure up and don't spare the vasoconstrictors. Br J Anaesth 2004; 92:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/74\">",
"      Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/75\">",
"      Choo KJL, Simons FER, Sheikh A. Glucocorticocoids for the treatment of anaphylaxis (protocol). Cochrane Database Syst Rev 2009; :CD007596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/76\">",
"      Seto A, Einarson T, Koren G. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol 1997; 14:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/77\">",
"      Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011; 128:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/78\">",
"      Hilbert J, Radwanski E, Affrime MB, et al. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988; 28:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/79\">",
"      Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev 2012; 4:CD007596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/80\">",
"      Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005; 95:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/81\">",
"      Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 371:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/82\">",
"      Hepner DL, Castells MC, Tsen LC. Should local anesthetic allergy testing be routinely performed during pregnancy? Anesth Analg 2003; 97:1853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/83\">",
"      Macy E. Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization. Ann Allergy Asthma Immunol 2006; 97:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/84\">",
"      Balestrieri PJ, Ferguson JE 2nd. Management of a parturient with a history of local anesthetic allergy. Anesth Analg 2003; 96:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/85\">",
"      Wendel GD Jr, Stark BJ, Jamison RB, et al. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985; 312:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/27/7610/abstract/86\">",
"      Chisholm CA, Katz VL, McDonald TL, Bowes WA Jr. Penicillin desensitization in the treatment of syphilis during pregnancy. Am J Perinatol 1997; 14:553.",
"     </a>",
"    </li>",
"    <li>",
"     Information about different forms of medical identification for patients with allergies is available on the website of the American Academy of Allergy, Asthma, and Immunology. www.aaaai.org (Accessed on January 27, 2010).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 393 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-956556EC73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7610=[""].join("\n");
var outline_f7_27_7610=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mother",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Fetus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TRIGGERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Anesthetic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Oxytocin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Intravenous iron",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laminaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Natural rubber latex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Other causes of laryngeal edema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other causes of hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Maternal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Intramuscular epinephrine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Supplemental oxygen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Fluid resuscitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Other measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Fetal monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Refractory anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Patients with drug allergies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Patients with latex allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Patients with insect sting allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Emergency preparedness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/393\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/393|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/26/39328\" title=\"figure 1\">",
"      Potential symptoms and signs of anaphylaxis during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/20/15690\" title=\"figure 2\">",
"      Treatment of anaphylaxis during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/393|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?2/42/2722\" title=\"form 1\">",
"      Anaphylaxis action plan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/393|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/36/21068\" title=\"table 1\">",
"      Symptoms and signs of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/43/23228\" title=\"table 2\">",
"      Anaphylaxis diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/61/41948\" title=\"table 3\">",
"      Differential diagnosis of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/26/14763\" title=\"table 4\">",
"      Diff dx of anaphylaxis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/47/9981\" title=\"table 5\">",
"      Anaphylaxis treatment in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/26/16813\" title=\"table 6\">",
"      Emergent management of anaphylaxis in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/62/34792?source=related_link\">",
"      Allergic reactions to local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=related_link\">",
"      Allergy to penicillins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15016?source=related_link\">",
"      Amniotic fluid embolism syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/62/24554?source=related_link\">",
"      An approach to the patient with drug allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9401?source=related_link\">",
"      Anaphylaxis: Confirming the diagnosis and determining the trigger(s)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/1/12313?source=related_link\">",
"      Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=related_link\">",
"      Chemoprophylaxis for the prevention of neonatal group B streptococcal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38888?source=related_link\">",
"      Differential diagnosis of anaphylaxis in children and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=related_link\">",
"      Evaluation and management of severe sepsis and septic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19272?source=related_link\">",
"      Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33864?source=related_link\">",
"      Hereditary angioedema: Pathogenesis and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=related_link\">",
"      Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=related_link\">",
"      Hypovolemic shock in children: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34071?source=related_link\">",
"      Idiopathic anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/7/23674?source=related_link\">",
"      Intrapartum fetal heart rate assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40809?source=related_link\">",
"      Laboratory tests to support the clinical diagnosis of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9785?source=related_link\">",
"      Latex allergy: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40070?source=related_link\">",
"      Latex allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=related_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42809?source=related_link\">",
"      Perioperative anaphylaxis: Clinical manifestations, etiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/20/27978?source=related_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=related_link\">",
"      Prescribing epinephrine for anaphylaxis self-treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/52/3914?source=related_link\">",
"      Recognition and management of allergic disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=related_link\">",
"      Seafood allergies: Fish and shellfish",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/61/4057?source=related_link\">",
"      Syphilis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10346?source=related_link\">",
"      Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25578?source=related_link\">",
"      Treatment of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13639?source=related_link\">",
"      Treatment of severe hypovolemia or hypovolemic shock in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_27_7611="Interpretation reflex test";
var content_f7_27_7611=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F81257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F81257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Interpretation of reflex test results after identification of a R117T mutation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       R117H + 5T on one chromosome plus &Delta;F508 on the other chromosome",
"      </td>",
"      <td>",
"       Classic cystic fibrosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Other combinations and male fetus",
"      </td>",
"      <td>",
"       CBAVD only",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       R117H + &Delta;F508 on opposite chromosomes",
"      </td>",
"      <td>",
"       CBAVD",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       R117H + 5T on opposite chromosomes",
"      </td>",
"      <td>",
"       CBAVD",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       R117H + 7T on opposite chromosomes",
"      </td>",
"      <td>",
"       CBAVD",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       5T/5T homozygosity (5T on each chromosome)",
"      </td>",
"      <td>",
"       CBAVD",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CBAVD: congenital bilateral absence of the vas deferens.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7611=[""].join("\n");
var outline_f7_27_7611=null;
var title_f7_27_7612="Drugs that cause hypoglycemia";
var content_f7_27_7612=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F52892&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F52892&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs other than antihyperglycemic agents and alcohol reported to cause hypoglycemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Moderate quality of evidence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cibenzoline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gatifloxacin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pentamidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Indomethacin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucagon (during endoscopy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Low quality of evidence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chloroquineoxaline sulfonamide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Artesunate/artemisin/artemether",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IGF-I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lithium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Propoxyphene/dextropropoxyphene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Very low quality of evidence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Drugs with &gt;25 cases of hypoglycemia identified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angiotensin converting enzyme inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angiotensin receptor antagonists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <sub>",
"         &beta;",
"        </sub>",
"        -Adrenergic receptor antagonists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Levofloxacin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mifepristone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Disopyramide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trimethoprim-sulfamethoxazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Heparin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6-Mercaptopurine",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94:709. Copyright &copy; 2009 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7612=[""].join("\n");
var outline_f7_27_7612=null;
var title_f7_27_7613="Contraindications to cardiac transplantation";
var content_f7_27_7613=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F83788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F83788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Contraindications to cardiac transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Absolute contraindications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Systemic illness with a life expectancy &lt;two years despite HT, including:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Active or recent solid organ or blood malignancy within five years (eg, leukemia, low-grade neoplasms of prostate with persistently elevated prostate-specific antigen)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        AIDS with frequent opportunistic infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Systemic lupus erythematosus, sarcoid, or amyloidosis that has multisystem involvement and is still active",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Irreversible renal or hepatic dysfunction in patients considered for only HT",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Significant obstructive pulmonary disease (FEV",
"        <sub>",
"         1",
"        </sub>",
"        &lt;1 L/min)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fixed pulmonary hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pulmonary artery systolic pressure &gt;60 mmHg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mean transpulmonary gradient &gt;15 mmHg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pulmonary vascular resistance &gt;6 Wood units",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Relative contraindications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age &gt;72 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any active infection (with exception of device-related infection in VAD recipients)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Active peptic ulcer disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe diabetes mellitus with end-organ damage (neuropathy, nephropathy, or retinopathy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Severe peripheral vascular or cerebrovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Peripheral vascular disease not amenable to surgical or percutaneous therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Symptomatic carotid stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ankle brachial index &lt;0.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Uncorrected abdominal aortic aneurysm &gt;6 cm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Morbid obesity (body mass index &gt;35 kg/m",
"        <sup>",
"         2",
"        </sup>",
"        ) or cachexia (body mass index &lt;18 kg/m",
"        <sup>",
"         2",
"        </sup>",
"        )",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Creatinine &gt;2.5 mg/dL or creatinine clearance &lt;25 mL/min*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bilirubin &gt;2.5 mg/dL, serum transaminases &gt;3X, INR &gt;1.5 off warfarin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe pulmonary dysfunction with FEV",
"        <sub>",
"         1",
"        </sub>",
"        &lt;40 percent normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recent pulmonary infarction within&nbsp;six to eight weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficult-to-control hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Irreversible neurological or neuromuscular disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Active mental illness or psychosocial instability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug, tobacco, or alcohol abuse within&nbsp;six months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heparin-induced thrombocytopenia within 100 days",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     INR: international normalized ratio.",
"     <br/>",
"     * May be suitable for HT if inotropic support and hemodynamic management produce a creatinine 2 mg/dL and creatinine clearance 50 mL per minute. Transplantation may also be advisable as combined heart-kidney transplantation.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mancini D, Lietz K. Selection of Cardiac Transplantation Candidates in 2010. Circulation 2010; 122:174. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7613=[""].join("\n");
var outline_f7_27_7613=null;
var title_f7_27_7614="Pathogenesis end stage HCM";
var content_f7_27_7614=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypothetical model for the pathogenesis of the end-stage phase of hypertrophic cardiomyopathy with left ventricular wall thinning and cavity enlargement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 296px; height: 458px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Indicates the following possibilities: 1) enhanced myocardial oxygen requirements and reduced myocardial capillary density relative to marked left ventricular hypertrophy (LVH); and 2) increased diastolic wall tension and coronary vascular resistance resulting from abnormal LV relaxation and impaired filling.",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Maron, BJ, Spirito, P, Am J Cardiol 1998; 81:1339.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7614=[""].join("\n");
var outline_f7_27_7614=null;
var title_f7_27_7615="Diagnosis neurosyphilis HIV infected";
var content_f7_27_7615=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F71518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F71518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Algorithm for the diagnosis of neurosyphilis in a patient with HIV infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 610px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ARV: antiretroviral drugs; CD4: cluster determinant 4 T lymphocyte; CSF: cerebrospinal fluid; EIA: syphilis enzyme immunoassay; FTA-ABS: fluorescent treponemal antibody-absorbed test; HIV: human immunodeficiency virus; LP: lumbar puncture; NS: neurosyphilis; RNA: ribonucleic acid; RPR: rapid plasma reagin test; TPPA: Treponema pallidum particle agglutination test; VDRL: Venereal Disease Research Laboratory test; WBC: white blood cell count.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christina M. Marra, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_27_7615=[""].join("\n");
var outline_f7_27_7615=null;
